LIFE, ACCIDENT AND HEALTH, Series 4-2 Accident and Health (General)
ColoradoRegulations
Ask Donna
How this section applies to your facts.
Code of Colorado Regulations › 700 Department of Regulatory Agencies › 702 Division of Insurance › 3 CCR 702-4 Series 4-2
Text
Regulation 4-2-1
REPLACEMENT OF INDIVIDUAL ACCIDENT AND SICKNESS
INSURANCE
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Rules
Section 6
Additional Rules for the Replacement of Health Benefit Plans
Section 7
Incorporation by Reference
Section 8
Severability
Section 9
Enforcement
Section 10
Effective Date
Section 11
History
Appendix A Notice to Applicant Regarding Replacement of Accident and Sickness
Insurance
Appendix B Notice to Applicant Regarding Replacement of a Health Benefit Plan
Section 1
Authority
This amended regulation is promulgated and adopted by the Commissioner of
Insurance under the authority of §§ 10-1-109, 10-3-1110, and 10-16-109, C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to reduce the opportunity for misrepresentation and
other unfair practices and methods of competition in the business of insurance. The
scope of this regulation includes persons covered by an individual health care coverage
plan offered by a health maintenance organization and individual accident and sickness
insurance policies or plans, who are considering replacement of their coverage.
Section 3
Applicability
This regulation shall apply to individual accident and sickness insurance policies and all
service or indemnity contracts offered by entities subject to Part 2, Part 3 and Part 4 of
Article 16 of Title 10, except conversion to an individual or family policy from a group,
blanket or group type policy, or any other insurance that is covered by a separate state
statute.
Section 4
Definitions
A.
“Accident and sickness insurance” means, for the purposes of this regulation, a
policy, plan, contract, agreement, statement of coverage, rider or endorsement
that provides accident or sickness benefits or medical, surgical or hospital
benefits, whether on an indemnity, reimbursement, service or prepaid basis,
except when issued in connection with another kind of insurance other than life
and except disability, waiver of premium and double indemnity benefits included
in life insurance and annuity contracts. For the purposes of this regulation,
accident and sickness insurance includes health coverage plans.
B.
“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.
C.
“Direct response” means, for the purposes of this regulation, a solicitation
through a sponsoring or endorsing entity or individually, solely through mail,
telephone, the internet, or other mass communication media.
D.
“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),
C.R.S.
E.
“Health coverage plan” shall have the same meaning as found at § 10-16-
102(34), C.R.S.
Section 5
Rules
A.
Application forms shall include the following questions designed to elicit
information as to whether, as of the date of the application, the applicant has an
accident and sickness insurance policy or health coverage plan in force, or
whether an accident and sickness insurance policy or health coverage plan is
intended to replace or be in addition to any other accident and sickness
insurance policy or health coverage plan presently in force. A supplementary
application or other form to be signed by the applicant and producer containing
such questions and statements may be used.
1.
Statements
a.
You normally do not require more than one of the same type of
policy.
b.
If you purchase this policy, you may want to evaluate your existing
health insurance and decide if you need multiple coverages.
c.
You may be eligible for benefits under Medicaid or Medicare and
may not need another health insurance policy. If you are eligible for
Medicare, you may want to purchase a Medicare supplement
insurance policy.
d.
If you are eligible for Medicare due to age or disability, counseling
services are available in Colorado to provide advice concerning
your purchase of Medicare supplement insurance and concerning
medical assistance through the state Medicaid program, Health
First Colorado.
2.
Questions
To the best of your knowledge:
a.
Do you have another health insurance policy or contract in force?
(1)
If so, with which company?
(2)
If so, do you intend to replace your current health insurance
policy or contract with this policy?
b.
Do you have any other health insurance that provides benefits
similar to this accident and sickness policy?
(1)
If so, with which company?
(2)
What kind of policy?
c.
Are you covered for medical assistance through the state Medicaid
program, Health First Colorado:
(1)
As a Specified Low-Income Medicare Beneficiary (SLMB)?
(2)
As a Qualified Medicare Beneficiary (QMB)?
(3)
For other Medicaid medical benefits?
B.
Producers must list all other accident and sickness insurance policies or
contracts they have sold to the applicant.
1.
List policies and/or contracts sold which are still in force; and
2.
List policies and/or contracts sold in the past five (5) years which are no
longer in force.
C.
In the case of a direct response carrier, a copy of the application or supplemental
form, signed by the applicant, and acknowledged by the carrier, shall be returned
to the applicant by the carrier upon delivery of the policy.
D.
Delivery of Replacement Notice
1.
Upon determining that a sale will involve replacement of an accident and
sickness insurance policy or health coverage plan, a carrier, other than a
direct response carrier, or its producer, shall furnish the applicant, prior to
issuance or delivery of the accident and sickness insurance policy or
health coverage plan, a notice regarding replacement of accident and
sickness insurance. One (1) copy of such notice signed by the applicant
and producer, except where the coverage is sold without a producer, shall
be provided to the applicant and an additional signed copy shall be
retained by the carrier.
2.
A direct response carrier shall deliver to the applicant, at the time of
issuance of the policy, the appropriate notice, located in Appendix A or B
of this regulation.
E.
The notices required by subsection 5.D. must be provided in the format
prescribed and adopted by the Commissioner of Insurance and are provided in
Appendices A and B of this regulation.
F.
Paragraph 1. of the notices provided in Appendices A and B, may be deleted by
the carrier if the replacement does not involve the application of a new pre-
existing condition limitation.
G.
Failure to comply with the requirements of this section 5 constitutes an unfair
method of competition and an unfair or deceptive act or practice in the business
of insurance which is prohibited under § 10-3-1104, C.R.S.
Section 6
Additional Rules for the Replacement of Health Benefit Plans
A.
Carriers are not required to provide the notice in Appendix B when an applicant is
replacing his or her current individual health benefit plan with another individual
health benefit plan during the annual open enrollment period or if the
replacement is due to eligibility for a special enrollment due to one or more of the
triggering events listed in Colorado Insurance Regulation 4-2-43.
B.
Carriers are required to provide the notice in Appendix B when an applicant is
replacing his or her current individual health benefit plan with an accident and
sickness insurance policy or health coverage plan which does not meet the
definition of a health benefit plan.
Section 7
Incorporation by Reference
Colorado Insurance Regulation 4-2-43, 3 CCR 702-4 published by the Colorado
Division of Insurance shall mean Colorado Insurance Regulation 4-2-43, 3 CCR 702-4
as published on the effective date of this regulation and does not include later
amendments to, or editions of, Colorado Insurance Regulation 4-2-43, 3 CCR 702-4.
Colorado Insurance Regulation 4-2-43, 3 CCR 702-4 may be examined during regular
business hours at the Colorado Division of Insurance, 1560 Broadway, Suite 850,
Denver, Colorado 80202 or by visiting the Colorado Division of Insurance website at
www.dora.colorado.gov/insurance. Certified copies of Colorado Insurance Regulation 4-
2-43, 3 CCR 702-4 are available from the Division of Insurance for a fee.
Section 8
Severability
If any provision of this regulation or the application of it to any person or circumstances
is for any reason held to be invalid, the remainder of this regulation shall not be
affected.
Section 9
Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspensions or revocation of license, subject to the requirements of due
process.
Section 10 Effective Date
This regulation is effective April 1, 2018.
Section 11 History
Originally issued as Regulation 74-2, effective March 15, 1974.
Amended December 22, 1975, effective January 1, 1976.
Amended effective January 14, 1977.
Renumbered on June 1, 1992.
Repealed and Repromulgated in full, effective February 1, 2001.
Amended Regulation 4-2-1, effective May 1, 2010.
Amended Regulation effective November 1, 2013.
Amended Regulation effective April 1, 2018.
Appendix A
NOTICE TO APPLICANT
REGARDING REPLACEMENT OF
ACCIDENT AND SICKNESS INSURANCE
[Carrier Name and Address]
According to [your application] [the information furnished by you], you intend to lapse or
otherwise terminate your present policy and replace it with a policy to be issued by
[carrier name]. [Your new policy will provide [number of days of the free look period]
days within which you may decide without cost whether you want to keep the policy.]
You should review this new coverage carefully. Compare it with all accident and
sickness coverage you now have. If, after due consideration, you find the purchase of
this accident and sickness coverage is a wise decision, you should evaluate the need
for other accident and sickness coverage you have that may duplicate this policy.
STATEMENT TO APPLICANT BY CARRIER OR PRODUCER:
I have reviewed your current health coverage. To the best of my knowledge, this
accident and sickness policy will not duplicate your existing coverage because you
intend to terminate your existing coverage. The replacement policy is being purchased
for the following reason(s)(check one):
______
Additional benefits
______
No change in benefits, but lower premiums
______
Fewer benefits and lower premiums
______
Other. (Please specify.)
1.
Health conditions which you may presently have (pre-existing conditions) may
not be immediately or fully covered under the new policy. This could result in the
denial or delay of a claim for benefits under the new policy, whereas a similar
claim may have been payable under your present policy.
2.
If you wish to terminate your present policy and replace it with new coverage, be
certain to truthfully and completely answer all questions on the application
concerning your medical and health history. Failure to include all material medical
information on an application may provide a basis for the company to deny any
future claims and to refund your premium as though your policy had never been
in force. After the application has been completed and before you sign it, review it
carefully to be certain that all information has been properly recorded. [If the
policy or contract is guaranteed issued this paragraph need not appear.]
Do not cancel your current policy until you have received your new policy and are sure
that you want to keep it.
_________________________________________
(Signature of Producer or Other Representative) *
[Typed Name and Address of Carrier, Producer, or Other Representative]
[_________________________________________
(Carrier Acknowledgement of Receipt and Review) **
_________________________________________]
(Date)
_________________________________________
(Applicant’s Signature)
_________________________________________
(Date)
* Signature not required for direct response sales.
** For use by direct response carriers.
Appendix B
NOTICE TO APPLICANT
REGARDING REPLACEMENT OF A HEALTH BENEFIT PLAN
[Carrier Name and Address]
According to [your application] [the information furnished by you], you intend to lapse or
otherwise terminate your present policy and replace it with a policy to be issued by
[carrier name]. [Your new policy will provide [number days of free look period] days
within which you may decide without cost whether you want to keep the policy.]
You should review this new coverage carefully. Compare it with all accident and
sickness coverage you now have. If, after due consideration, you find the purchase of
this accident and sickness coverage is a wise decision, you should evaluate the need
for other accident and sickness coverage you have that may duplicate this policy.
STATEMENT TO APPLICANT BY CARRIER OR PRODUCER:
I have reviewed your current accident and sickness insurance coverage, which provides
comprehensive medical coverage. To the best of my knowledge, this accident and
sickness policy will not duplicate your existing coverage because you intend to
terminate your existing coverage. The replacement policy is being purchased for the
following reason(s)(check one):
______
Additional benefits
______
No change in benefits, but lower premiums
______
Fewer benefits and lower premiums
______
Other. (Please specify.)
1.
Health conditions which you may presently have (pre-existing conditions) may
not be immediately or fully covered under the new policy. This could result in the
denial or delay of a claim for benefits under the new policy, whereas a similar
claim may have been payable under your present policy, which provides
comprehensive coverage.
2.
If you wish to terminate your present policy and replace it with new coverage, be
certain to truthfully and completely answer all questions on the application
concerning your medical and health history. Failure to include all material medical
information on an application may provide a basis for the company to deny any
future claims and to refund your premium as though your policy had never been
in force. After the application has been completed and before you sign it, review it
carefully to be certain that all information has been properly recorded. [If the
policy or contract is guaranteed issued this paragraph need not appear.]
Do not cancel your current policy until you have received your new policy and are sure
that you want to keep it.
________________________________________
(Signature of Producer or Other Representative) *
[Typed Name and Address of Carrier, Producer, or Other Representative]
[_________________________________________
(Carrier Acknowledgement of Receipt and Review) **
_________________________________________]
(Date)
__________________________________________
(Applicant’s Signature)
___________________________________________
(Date)
* Signature not required for direct response sales.
** For use by direct response carriers.
Regulation 4-2-2
HOSPITAL INDEMNITY AND DISABILITY INCOME POLICIES
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Rules
Section 6
Severability
Section 7
Enforcement
Section 8
Effective Date
Section 9
History
Section 1
Authority
This regulation is promulgated and adopted by the Commissioner of Insurance under
the authority of § § 10-1-109 and 10-16-109, C.R.S.
Section 2
Scope and Purpose
This regulation prohibits insurers from refusing to pay benefits under certain contracts
because of hospitalization in government hospitals.
Section 3
Applicability
This regulation applies to all hospital indemnity and disability income policies, contracts,
riders, endorsements, etc., which provide benefits because of hospitalization or
disability originating out of hospitalization hereinafter referred to as hospital indemnity
and disability income policies. It does not apply to hospital expense policies.
Section 4
Definitions
For the purposes of this regulation:
A.
“Disability income policy” means, for the purposes of this regulation, a policy that
provides periodic payments to replace income lost when the insured is unable to
work as the result of a sickness or injury.
B.
“Government hospital” means, for the purposes of this regulation, any hospital
under governmental control whether federal, state, county or city. It includes
Veterans Administration hospitals.
C.
“Hospital indemnity policy” means, for the purposes of this regulation, a policy
that provides a stated daily, weekly or monthly payment while the insured is
hospitalized, regardless of expenses incurred and regardless of whether or not
other insurance is in force. The insured can use the daily, weekly or monthly
benefit as he or she chooses, for hospital or other expenses.
Section 5
Rules
All hospital indemnity and disability income policies delivered or issued for delivery in
the State of Colorado which provide benefits predicated on hospitalization will not in any
way deny such benefits on the basis that such hospitalization was in a government
hospital.
Section 6
Severability
If any provision of this regulation or the application of it to any person or circumstance is
for any reason held to be invalid, the remainder of the regulation shall not be affected.
Section 7
Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspension or revocation of license, subject to the requirements of due
process.
Section 8
Effective Date
This regulation shall be effective December 1, 2013.
Section 9
History
Originally issued as Regulation 74-4, effective July 1, 1974.
Renumbered as Regulation 4-2-2, effective June 1, 1992.
Repealed and Repromulgated in full, effective January 1, 2001.
Amended Regulation 4-2-2, effective July 1, 2010.
Amended Regulation 4-2-2, effective December 1, 2013.
Regulation 4-2-3
ADVERTISEMENTS OF ACCIDENT AND SICKNESS
INSURANCE
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Method of Disclosure of Required Information
Section 6
Format and Content of Advertisements
Section 7
Advertisement of Benefits Payable, Losses Covered or Premiums Payable
Section 8
Necessity for Disclosing Policy Provisions Relating to Renewability,
Cancellability and Termination
Section 9
Standards for Marketing
Section 10
Testimonials or Endorsements by Third Parties
Section 11
Use of Statistics
Section 12
Identification of Plan or Number of Policies
Section 13
Disparaging Comparisons and Statements
Section 14
Jurisdictional Licensing and Status of Insurer
Section 15
Identity of Insurer
Section 16
Group or Quasi-Group Implications
Section 17
Introductory, Initial or Special Offers
Section 18
Statements about an Insurer
Section 19
Enforcement Procedures
Section 20
Severability
Section 21
Incorporated Materials
Section 22
Enforcement
Section 23
Effective Date
Section 24
History
Section 1
Authority
This regulation is promulgated under the authority of §§ 10-1-109 and 10-3-1110, C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to establish minimum criteria to assure proper and
accurate description and to protect prospective purchasers with respect to the
advertisement of accident and sickness insurance. This regulation assures the clear
and truthful disclosure of the benefits, limitations and exclusions of policies sold as
accident and sickness insurance by the establishment of standards of conduct in the
advertising of accident and sickness insurance in a manner that prevents unfair,
deceptive and misleading advertising and is conducive to accurate presentation and
description to the insurance-buying public through the advertising media and material
used by insurance producers and companies.
Section 3
Applicability
A.
This regulation shall apply to any accident and sickness insurance
“advertisement”, as that term is defined, intended for presentation, distribution or
dissemination in Colorado when such presentation, distribution or dissemination
is made either directly or indirectly by or on behalf of an insurer or producer, as
those terms are defined in the Colorado Revised Statutes and this regulation.
B.
Every insurer shall establish and at all times maintain a system of control over
the content, form and method of dissemination of all advertisements of its
policies. All of the insurer's advertisements, regardless of by whom written,
created, designed or presented, shall be the responsibility of the insurer whose
policies are advertised.
C.
Advertising materials that are reproduced in quantity shall be identified by form
numbers or other identifying means. The identification shall be sufficient to
distinguish an advertisement from any other advertising materials, policies,
applications or other materials used by the insurer.
Section 4
Definitions
A.
“ACA” means, for the purposes of this regulation, the Patient Protection and
Affordable Care Act, Pub. L. 111-148 and the Health Care and Education
Reconciliation Act of 2010, Pub. L. 111-152.
B.
“Accident and sickness insurance policy” means, for the purposes of this
regulation, a policy, plan, certificate, contract, agreement, statement of coverage,
rider or endorsement that provides accident or sickness benefits or medical,
surgical or hospital benefits, whether on an indemnity, reimbursement, service or
prepaid basis, except when issued in connection with another kind of insurance
other than life and except disability, waiver of premium and double indemnity
benefits included in life insurance and annuity contracts.
1.
An accident and sickness insurance policy does not include a Medicare
supplement insurance policy or any other type of accident and sickness
insurance with advertising guidelines covered by a separate statute and/or
regulation.
2.
The language “except disability, waiver of premium and double indemnity
benefits included in life insurance and annuity contracts” means it does
not include disability, waiver of premium and double indemnity benefits
included in life insurance, endowment or annuity contracts or contracts
supplemental to the above contracts that contain only provisions that:
a.
Provide additional benefits in case of death or dismemberment or
loss of sight by accident; or
b.
Operate to safeguard the contracts against lapse or to give a
special surrender value, special benefit or an annuity in the event
that the insured or annuitant becomes totally and permanently
disabled as defined by the contract or supplemental contract.
C.
“Advertisement” means, for the purposes of this regulation, printed and published
material, audio visual material, and descriptive literature of an insurer used in
direct mail, newspapers, magazines, radio scripts, TV scripts, web sites and
other Internet displays or communications, other forms of electronic
communications, billboards and similar displays.
1.
“Advertisement” also means:
a.
Descriptive literature and sales aids of all kinds issued by an
insurer or producer for presentation to members of the insurance-
buying public, such as circulars, leaflets, booklets, depictions,
illustrations, form letters and lead-generating devices of all kinds;
b.
Digital advertisements such as any advertisement delivered
through electronic means including email, text message, social
media, mobile applications, search engines, websites, web-based
platforms, chat interfaces, or automated electronic communication
tools.
c.
Prepared sales talks, presentations and material for use by
producers whether prepared by the insurer or producer;
d
Summary of Benefits and Coverage (SBC) forms; and
e.
The Colorado Supplement to the Summary of Benefits and
Coverage Form as found in Colorado Insurance Regulation 4-2-20.
2.
The definition of “advertisement” includes advertising material included
with a policy when the policy is delivered and material used in the
solicitation of renewals and reinstatements.
3.
The definition of “advertisement” extends to the use of all media for
communications to the general public; to the use of all media for
communications to specific members of the general public; and to the use
of all media for communications by insurers or producers.
4.
The definition of “advertisement” does not include:
a.
Material used solely for the training and education of an insurer’s
employees or producers;
b.
Material used in-house by insurers;
c.
Communications within an insurer’s own organization not intended
for dissemination to the public;
d.
Individual communications of a personal nature with current
policyholders other than material urging the policyholders to
increase or expand coverages;
e.
Correspondence between a prospective group or blanket
policyholder and an insurer in the course of negotiating a group or
blanket contract;
f.
Court-approved material ordered by a court to be disseminated to
policyholders; or
g.
A general announcement from a group or blanket policyholder to
eligible individuals on an employment or membership list that a
contract or program has been written or arranged, provided that the
announcement clearly indicates that it is preliminary to the issuance
of a booklet and that the announcement does not describe the
specific benefits under the contract or program nor describe
advantages as to the purchase of the contract or program. This
does not prohibit a general endorsement of the program by the
sponsor.
D.
“Certificate” means, for the purposes of this regulation, a statement of the
coverage and provisions of a group accident and sickness insurance policy,
which has been delivered or issued for delivery in this state and includes riders,
endorsements and enrollment forms, if attached.
E.
“Exception” means, for the purposes of this regulation, any provision in a policy
whereby coverage for a specified hazard is entirely eliminated; it is a statement
of a risk not assumed under the policy.
F.
“Format” means, for the purposes of this regulation, the arrangement of the text
and the captions.
G.
“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),
C.R.S.
H.
“Health coverage plan” shall have the same meaning as found at § 10-16-
102(34), C.R.S.
I.
“Institutional advertisement” means, for the purposes of this regulation, an
advertisement having as its sole purpose the promotion of the reader’s, viewer’s
or listener’s interest in the concept of accident and sickness insurance, or the
promotion of the insurer as a seller of accident and sickness insurance. Insurers
are required to comply with section 15.A. of the regulation, clearly identifying the
name of the insurer.
J.
“Insurer” shall have the same meaning as “carrier” as found at § 10-16-102(8),
C.R.S., and applies to any carrier subject to Title 10, Article 16, Parts 2, 3 or 4.
K.
“Invitation to contract” means, for the purposes of this regulation, an
advertisement that is neither an “invitation to inquire” nor an “institutional
advertisement”.
L.
“Invitation to inquire” means, for the purposes of this regulation, an advertisement
having as its objective the creation of a desire to inquire further about accident
and sickness insurance and that is limited to a brief description of the loss for
which benefits are payable, but may contain the dollar amount of benefits
payable and the period of time during which benefits are payable.
1.
An “invitation to inquire” shall not refer to cost.
2.
An “invitation to inquire” shall contain a provision in the following or
substantially similar form:
“This policy has [exclusions] [limitations] [reduction of benefits] [terms
under which the policy may be continued in force or discontinued]. For
costs and complete details of the coverage, call [or write] your insurance
producer or the company [whichever is applicable].”
M.
“Juxtaposition” means, for the purposes of this regulation, side-by-side or
immediately above or below.
N.
“Lead-generating device” means, for the purposes of this regulation, any
communication directed to the public that, regardless of form, content or stated
purpose is intended to result in the compilation or qualification of a list containing
names and other personal information to be used to solicit residents of this state
for the purchase of accident and sickness insurance.
O.
“Limitation” means, for the purposes of this regulation, a provision that restricts
coverage under the policy other than an exception or a reduction.
P.
“Limited benefit health coverage” means, for the purposes of this regulation, any
type of health coverage that is not provided by a health benefit plan, as found at
§ 10-16-102(32), C.R.S.
This subsection does not apply to policies designed to provide coverage for long-
term care or to Medicare supplement insurance.
Q.
“Marketing” means, for the purposes of this regulation, any activity or effort
directed toward the public which is intended to promote or sell products or
services.
R.
“Prominently” or “conspicuously” means, for the purposes of this regulation, that
the information to be disclosed “prominently” or “conspicuously” shall be
presented in a manner that is noticeably set apart from other information or
images in the advertisement.
S.
“Reduction” means, for the purposes of this regulation, a provision that reduces
the amount of the benefit; a risk of loss is assumed but payment upon the
occurrence of the loss is limited to some amount or period less than would be
otherwise payable had the reduction not been used.
T.
“Short-term limited duration health insurance policy” shall have the same
meaning as found at § 10-16-102(60), C.R.S.
U.
“Summary of Benefits and Coverage” or “SBC” means, for the purposes of this
regulation, the form required by 45 C.F.R. § 147.200(a).
Section 5
Method of Disclosure of Required Information
All information, exceptions, limitations, reductions and other restrictions required to be
disclosed by this regulation shall be set out conspicuously and in close conjunction to
the statements to which the information relates or under appropriate captions of such
prominence that it shall not be minimized, rendered obscure or presented in an
ambiguous fashion or intermingled with the context of the advertisements so as to be
confusing or misleading. This regulation permits, but is not limited to, the use of either of
the following methods of disclosure:
A.
Disclosure in the description of the related benefits or in a paragraph set out in
close conjunction with the description of policy benefits; or
B.
Disclosure not in conjunction with the provisions describing policy benefits but
under appropriate captions of such prominence that the information shall not be
minimized, rendered obscure or otherwise made to appear unimportant. The
phrase “under appropriate captions” means that the title must be accurately
descriptive of the captioned material. Appropriate captions include the following:
“Exceptions”, “Exclusions”, “Conditions Not Covered”, and “Exceptions and
Reductions”. The use of captions such as the following are prohibited because
they do not provide adequate notice of the significance of the material: “Extent of
Coverage”, “Only these Exclusions”, or “Minimum Limitations”.
Section 6
Format and Content of Advertisements
A.
The format and content of an advertisement of an accident and sickness
insurance policy shall be sufficiently complete and clear to avoid deception or the
capacity or tendency to mislead or deceive.
B.
Distinctly different advertisements are required for publication in different media,
such as newspapers or magazines of general circulation as compared to
scholarly, technical or business journals and newspapers. Where an
advertisement consists of more than one piece of material, each piece of material
must, independent of all other pieces of material, conform to the disclosure
requirements of this regulation.
C.
Whether an advertisement has a capacity or tendency to mislead or deceive shall
be determined by the Commissioner from the overall impression that the
advertisement may be reasonably expected to create within the segment of the
public to which it is directed.
D.
Advertisements shall be truthful and not misleading in fact or implication. Words
or phrases, the meaning of which is clear only by implication or by familiarity with
insurance terminology, shall not be used.
E.
An insurer shall clearly identify its accident and sickness insurance policy as an
insurance policy. A policy trade name shall be followed by the words “insurance
policy” or similar words clearly identifying the fact that an insurance policy or
health benefits product (in the case of health maintenance organizations, prepaid
health plans and other direct service organizations) is being offered.
F.
An insurer, producer or other person shall not solicit a resident of this state for
the purchase of accident and sickness insurance in connection with or as the
result of the use of an advertisement by the person or any other persons, where
the advertisement:
1.
Contains any misleading representations or misrepresentations, or is
otherwise untrue, deceptive or misleading with regard to the information
imparted, the status, character or representative capacity of the person or
the true purpose of the advertisement; or
2.
Otherwise violates the provisions of this regulation.
G.
An insurer, producer or other person shall not solicit residents of this state for the
purchase of accident and sickness insurance through the use of a true or
fictitious name that is deceptive or misleading with regard to the status, character
or proprietary or representative capacity of the person or the true purpose of the
advertisement.
H.
An insurer is prohibited from representing or naming any health coverage plan as
a Bronze, Silver, Gold, or Platinum metal tier level of coverage unless that policy
is a health benefit plan as specified in § 10-16-103.4, C.R.S. Use of these terms
for a non-ACA compliant health coverage plan may be found to violate § 10-3-
1104(1)(a)(V), C.R.S. This prohibition also applies to short-term limited duration
health insurance policies.
I.
An insurer, producer, or other person is prohibited from advertising any health
coverage plan which is not ACA-compliant as an alternative to, equivalent to, or a
substitute for, a health benefit plan which meets federal and state requirements
under the ACA.
Section 7
Advertisements of Benefits Payable, Losses Covered or Premiums
Payable
A.
Covered Benefits
1.
The use of deceptive words, phrases or illustrations in advertisements of
accident and sickness insurance is prohibited.
2.
An advertisement that fails to state clearly the type of insurance coverage
being offered is prohibited.
3.
An advertisement shall not omit information or use words, phrases,
statements, references or illustrations if the omission of information or use
of words, phrases, statements, references or illustrations has the capacity,
tendency or effect of misleading or deceiving purchasers or prospective
purchasers as to the nature or extent of any policy benefit payable, loss
covered or premium payable. The fact that the policy offered is made
available to a prospective insured for inspection prior to consummation of
the sale or an offer is made to refund the premium if the purchaser is not
satisfied, does not remedy misleading statements.
4.
An advertisement shall not contain or use words or phrases such as “all”,
“full”, “complete”, “comprehensive”, “unlimited”, “up to”, “as high as”, “this
policy will help fill some of the gaps that Medicare and your present
insurance leave out”, “the policy will help to replace your income” (when
used to express loss of time benefits), or similar words and phrases, in a
manner that exaggerates a benefit beyond the terms of the policy.
5.
An advertisement of a hospital or other similar facility confinement benefit
that makes reference to the benefit being paid directly to the policyholder
is prohibited unless, in making the reference, the advertisement includes a
statement that the benefits may be paid directly to the hospital or other
health care facility if an assignment of benefits is made by the
policyholder. An advertisement of medical and surgical expense benefits
shall comply with this regulation in regard to the disclosure of assignments
of benefits to providers of services. Phrases such as “you collect”, “you get
paid”, “pays you”, or other words or phrases of similar import may be used
so long as the advertisement indicates that it is payable to the insured or
someone designated by the insured.
6.
An advertisement for basic hospital expense coverage, basic medical-
surgical expense coverage, basic hospital/medical-surgical expense
coverage, hospital confinement indemnity coverage, accident-only
coverage, specified disease coverage, specified accident coverage,
limited benefit health coverage or for coverage that covers only a certain
type of loss is prohibited if:
a.
The advertisement refers to a total benefit maximum limit payable
under the policy in any headline, lead-in or caption without, also in
the same headline, a lead-in or caption specifying the applicable
daily limits and other internal limits;
b.
The advertisement states a total benefit limit without stating the
periodic benefit payment, if any, and the length of time the periodic
benefit would be payable to reach the total benefit limit; or
c.
The advertisement prominently displays a total benefit limit that
would not, as a general rule, be payable under an average claim.
Section 7.A.6. does not apply to individual health benefit plans or disability
income insurance.
7.
Advertisements that emphasize total amounts payable under hospital,
medical or surgical accident and sickness insurance coverage or other
benefits in a policy, such as benefits for private duty nursing, are
prohibited unless the actual amounts payable per day for the indemnity or
benefits are stated.
8.
Advertisements that include examples of benefits payable under a policy
shall not use examples in a way that implies that the maximum benefit
payable under the policy will be paid, when less than maximum benefits
are paid for an average claim.
9.
When a range of benefit levels is set forth in an advertisement, it shall be
clear that the insured will receive only the benefit level written or printed in
the policy selected and issued. Language that implies that the insured
may select the benefit level at the time of filing claims is prohibited.
10.
Language in an advertisement that implies that the amount of benefits
payable under a loss-of-time policy may be increased at the time of claim
or disability according to the needs of the insured is prohibited.
11.
Advertisements for policies with premiums that are modest because of
their limited coverage or limited amount of benefits shall not describe
premiums as “low”, “low cost”, “budget” or use qualifying words of similar
import. The use of words such as “only” and “just” in conjunction with
statements of premium amounts when used to imply a bargain are
prohibited.
12.
Advertisements that state or imply that premiums will not be changed in
the future are prohibited unless the advertised policies expressly provide
that the premiums will not be changed in the future.
13.
An advertisement for a policy that does not require the premium to
accompany the application shall not overemphasize that fact and shall
clearly indicate under what circumstances coverage will become effective.
14.
An advertisement that exaggerates the effects of statutorily-mandated
benefits or required policy provisions or that implies that the provisions are
unique to the advertised policy is prohibited.
15.
An advertisement that implies that a common type of policy or a
combination of common benefits is “new”, “unique”, “a bonus”, “a
breakthrough”, or is otherwise unusual is prohibited. The addition of a
novel method of premium payment to an otherwise common plan of
insurance does not render it new or unique.
16.
Language in an advertisement that states or implies that each member
under a family contract is covered as to the maximum benefits advertised,
where that is not the fact, is prohibited.
17.
An advertisement that contains statements such as “anyone can apply”, or
“anyone can join”, other than with respect to a guaranteed-issue policy for
which administrative procedures exist to assure that the policy is issued
within a reasonable period of time after the application is received by the
insurer, is prohibited.
18.
An advertisement that states or implies immediate coverage of a policy is
prohibited unless administrative procedures exist so that the policy is
issued within fifteen (15) business days after the insurer receives the
completed application.
19.
An advertisement that contains statements such as “here is all you do to
apply”, or “simply” or “merely” to refer to the act of applying for a policy
that is not a guaranteed-issue policy is prohibited unless it refers to the
fact that the application is subject to acceptance or approval by the
insurer.
20.
An advertisement of accident and sickness insurance sold by direct
response shall not state or imply that because no insurance producer will
call and no commissions will be paid to producers that it is a low cost plan,
or use other similar words or phrases because the cost of advertising and
servicing the policies is a substantial cost in the marketing by direct
response.
21.
Applications, request forms for additional information and similar related
materials are prohibited if they resemble paper currency, bonds, stock
certificates, etc., or use any name, service mark, slogan, symbol or device
in a manner that implies that the insurer or the policy advertised is
connected with a government agency, such as the Social Security
Administration or the U.S. Department of Health and Human Services.
22.
An advertisement that implies in any manner that the prospective insured
may realize a profit from obtaining hospital, medical or surgical insurance
coverage is prohibited.
23.
An advertisement that uses words such as “extra”, “special” or “added” to
describe a benefit in the policy is prohibited. No advertisement of a benefit
for which payment is conditioned upon confinement in a hospital or similar
facility shall use words or phrases such as “tax-free”, “extra cash”, “extra
income”, “extra pay”, or substantially similar words or phrases because
these words and phrases have the capacity, tendency or effect of
misleading the public into believing that the policy advertised will, in some
way, enable them to make a profit from being hospitalized.
24.
An advertisement of a hospital or other similar facility confinement benefit
shall not advertise that the amount of the benefit is payable on a monthly
or weekly basis when, in fact, the amount of the benefit payable is based
upon a daily pro rata basis relating to the number of days of confinement
unless the statements of the monthly or weekly benefit amounts are in
juxtaposition with equally prominent statements of the benefit payable on
a daily basis. When the policy contains a limit on the number of days of
coverage provided, the limit shall appear in the advertisement.
25.
An advertisement of a policy covering only one disease or a list of
specified diseases shall not imply coverage beyond the terms of the policy.
Synonymous terms shall not be used to refer to any disease so as to imply
broader coverage than is the fact.
26.
An advertisement that is an invitation to contract for a specified disease
policy that provides lesser benefit amounts for a particular subtype of
disease, shall clearly disclose the subtype and its benefits. This provision
shall not apply to institutional advertisements.
27.
An advertisement of a specified disease policy providing expense benefits
shall not use the term “actual” when the policy only pays up to a limited
amount for expenses. Instead, the term “charges” or substantially similar
language should be used that does not create the misleading impression
that there is full coverage for expenses.
28.
An advertisement that describes any benefits that vary by age shall
disclose that fact.
29.
An advertisement that uses a phrase such as “no age limit”, if benefits or
premiums vary by age or if age is an underwriting factor, shall disclose
that fact.
30.
A television, radio, internet, mail or newspaper advertisement or lead-
generating device that is designed to produce leads either by use of a
coupon, a request to write or e-mail or to call the insurer or a subsequent
advertisement prior to contact shall include information disclosing that a
producer may contact the applicant.
31.
Advertisements, applications, requests for additional information and
similar materials are prohibited if they state or imply that the recipient has
been individually selected to be offered insurance or has had his or her
eligibility for the insurance individually determined in advance when the
advertisement is directed to all persons in a group or to all persons whose
names appear on a mailing list.
32.
An advertisement, including invitations to inquire or invitations to contract,
shall not employ devices that are designed to create undue fear or anxiety
in the minds of those to whom they are directed. Examples of prohibited
devices are:
a.
The use of phrases such as “cancer kills somebody every two
minutes” and “total number of accidents” without reference to the
total population from which the statistics are drawn;
b.
The exaggeration of the importance of diseases rarely or seldom
found in the class of persons to whom the policy is offered;
c.
The use of phrases such as “the finest kind of treatment”, implying
that the treatment would be unavailable without insurance;
d.
The reproduction of newspaper articles, magazine articles,
information from the Internet or other similar published material
containing irrelevant facts and figures;
e.
The use of images that unduly emphasize automobile accidents,
disabled persons or persons confined in beds who are in obvious
distress, persons receiving hospital or medical bills or persons
being evicted from their homes due to their medical bills;
f.
The use of phrases such as “financial disaster”, “financial distress”,
“financial shock”, or another phrase implying that financial ruin is
likely without insurance is only permissible in an advertisement for
major medical expense coverage, individual basic medical expense
coverage or disability income coverage, and only if the phrase does
not dominate the advertisement;
g.
The use of phrases or devices that unduly excite fear of
dependence upon relatives or charity; and
h.
The use of phrases or devices that imply that long sicknesses or
hospital stays are common among the elderly.
B.
Exceptions, Reductions and Limitations
1.
An advertisement shall not contain descriptions of policy limitations,
exceptions or reductions, worded in a positive manner to imply that it is a
benefit, such as describing a waiting period as a “benefit builder” or stating
“even preexisting conditions are covered after two years”. Words and
phrases used in an advertisement to describe the policy limitations,
exceptions and reductions shall fairly and accurately describe the negative
features of the limitations, exceptions and reductions of the policy offered.
2.
An advertisement that is an invitation to contract shall disclose those
exceptions, reductions and limitations affecting the basic provisions of the
policy.
3.
When a policy contains a waiting, elimination, probationary or similar time
period between the effective date of the policy and the effective date of
coverage under the policy or a time period between the date a loss occurs
and the date benefits begin to accrue for the loss, an advertisement that is
subject to the requirements of Section 7.B.2. shall prominently disclose
the existence of such periods.
4.
An advertisement shall not use the words “only”, “just”, “merely”,
“minimum”, “necessary” or similar words or phrases to describe the
applicability of any exceptions, reductions, limitations or exclusions such
as: “This policy is subject to the following minimum exceptions and
reductions.”
5.
An advertisement that is an invitation to contract that fails to disclose the
amount of any deductible or the percentage of any coinsurance factor is
prohibited.
6.
An advertisement for loss-of-time coverage that is an invitation to contract
that sets forth a range of amounts of benefit levels is prohibited unless it
also states that eligibility for the benefits is based upon condition of health,
income or other economic conditions, or other underwriting standards of
the insurer if that is the fact.
7.
An advertisement that refers to “hospitalization for injury or sickness”
omitting the word “covered” when the policy excludes certain sicknesses
or injuries, or that refers to “whenever you are hospitalized”, “when you go
to the hospital”, or “while you are confined in the hospital” omitting the
phrase “for covered injury or sickness”, if the policy excludes certain
injuries or sicknesses, is prohibited. Continued reference to “covered
injury or sickness” is not necessary where this fact has been prominently
disclosed in the advertisement and where the description of sicknesses or
injuries not covered is prominently set forth.
8.
An advertisement that fails to disclose that the definition of “hospital” does
not include certain facilities that provide institutional care such as a
nursing home, convalescent home or extended care facility, when the
facilities are excluded under the definition of hospital in the policy, is
prohibited.
9.
The term “confining sickness” shall be explained in an advertisement
containing the term. The explanation might be as follows: “Benefits are
payable for total disability due to confining sickness only so long as the
insured is necessarily confined indoors.” Captions such as “Lifetime
Sickness Benefits” or “Five-Year Sickness Benefits” are incomplete if the
benefits are subject to confinement requirements. When sickness benefits
are subject to confinement requirements, captions such as “Lifetime
House Confining Sickness Benefits” or “Five-Year House Confining
Sickness Benefits” would be permissible.
10.
An advertisement that fails to disclose any waiting or elimination periods
for specific benefits is prohibited.
11.
An advertisement for a policy providing benefits for specified illnesses
only, such as cancer, or for specified accidents only, such as automobile
accidents, or other policies providing benefits that are limited in nature,
shall clearly and conspicuously in prominent type state the limited nature
of the policy. The statement shall be worded in language identical to or
substantially similar to the following: “THIS IS A LIMITED POLICY”, “THIS
POLICY PROVIDES LIMITED BENEFITS”, or “THIS IS A CANCER ONLY
POLICY”.
Some advertisements disclose exceptions, reductions and limitations as
required, but the advertisement is so lengthy as to obscure the disclosure.
Where the length of an advertisement has this effect, special emphasis
must be given by changing the format to show the restrictions in a manner
that does not minimize, render obscure or otherwise make them appear
unimportant.
C.
Preexisting Conditions
1.
An advertisement that is an invitation to contract shall, in negative terms,
disclose the extent to which any loss is not covered if the cause of the loss
is traceable to a condition existing prior to the effective date of the policy.
The use of the term “preexisting condition” without an appropriate
definition or description shall not be used.
Negative features must be accurately set forth. Any limitation on benefits
including preexisting conditions also must be restated under a caption
concerning exclusions or limitations, notwithstanding that the preexisting
condition exclusion has been disclosed elsewhere in the advertisement.
2.
When an accident and sickness insurance policy does not cover losses
resulting from preexisting conditions, an advertisement of the policy shall
not state or imply that the applicant’s physical condition or medical history
will not affect the issuance of the policy or payment of a claim under the
policy. This regulation prohibits the use of the phrase “no medical
examination required” and phrases of similar import, but does not prohibit
explaining “guaranteed-issue”. If an insurer requires a medical
examination for a specified policy, the advertisement, if it is an invitation to
contract, shall disclose that a medical examination is required.
3.
When an advertisement contains an application form to be completed by
the applicant and returned by mail, the application form shall contain a
question or statement that reflects the preexisting condition provisions of
the policy immediately preceding the blank space for the applicant’s
signature. For example, the application form shall contain a question or
statement substantially as follows:
“Do you understand that this policy will not pay benefits during the first
[insert number] [years, months] after the issue date for a disease or
physical condition that you now have or have had in the past?
“YES”
Or substantially the following statement:
“I understand that the policy applied for will not pay benefits for any loss
incurred during the first [insert number] [years, months] after the issue
date on account of disease or physical condition that I now have or have
had in the past.”
Section 8
Necessity for Disclosing Policy Provisions Relating to Renewability,
Cancellability and Termination
A.
An advertisement that is an invitation to contract shall disclose the provisions
relating to renewability, cancellability and termination, and any modification of
benefits, losses covered, or premiums because of age or for other reasons, in a
manner that shall not minimize or render obscure the qualifying conditions.
B.
Advertisements of cancellable accident and sickness insurance policies shall
state that the insurer may cancel or renew the contract using language
substantially similar to the following: “This policy is renewable at the option of the
company.”, or “The company has the right to refuse renewal of this policy.”, or
“Renewable at the option of the insurer.”, or “This policy can be cancelled by the
company at any time.”
C.
Advertisements of insurance policies that are guaranteed renewable, cancellable
or renewable at the option of the insurer shall disclose that the insurer has the
right to increase premium rates if the policy so provides.
D.
Qualifying conditions that constitute limitations on the permanent nature of the
coverage shall be disclosed in advertisements of insurance policies that are
guaranteed renewable, cancellable or renewable at the option of the insurer.
Examples of qualifying conditions include, but are not limited to age limits;
reservation of a right to increase premiums; and the establishment of aggregate
limits.
1.
Provisions for reduction of benefits at stated ages shall be set forth. For
example, a policy may contain a provision that reduces benefits fifty
percent (50%) after age sixty (60) although it is renewable to age sixty-five
(65). Such a reduction shall be set forth. Also, a provision for the
elimination of certain hazards at any specific ages or after the policy has
been in force for a specified time shall be set forth.
2.
An advertisement for a policy that provides for step-rated premium rates
based upon the policy year or the insured’s attained age shall disclose the
rate increases and the times or ages at which the premiums increase.
Section 9
Standards for Marketing
A.
An insurer, directly or through its producers, shall:
1.
Establish marketing procedures to assure that any comparison of policies
by its producers will be fair and accurate;
2.
Establish marketing procedures assuring excessive insurance is not sold
or issued, except this requirement does not apply to group health benefit
plans and disability income coverage; and
3.
Establish auditable procedures for verifying compliance with Section 9.
B.
The following acts and practices are prohibited:
1.
Twisting. Knowingly making any misleading representation or incomplete
or fraudulent comparison of insurance policies or insurers for the purpose
of inducing, or tending to induce, a person to lapse, forfeit, surrender,
terminate, retain, pledge, assign, borrow on, or convert an insurance
policy, or to take out a policy of insurance with another insurer;
2.
High Pressure Tactics. Employing a method of marketing that has the
effect of inducing the purchase of insurance, or tends to induce the
purchase of insurance through force, fright, threat, whether explicit or
implied, or undue pressure to purchase or recommend the purchase of
insurance; and
3.
Cold Lead Advertising. Making use directly or indirectly of any method of
marketing that fails to disclose in a conspicuous manner that a purpose of
the method of marketing is solicitation of insurance and that contact will be
made by an insurance producer or insurer.
4.
The marketing of any health coverage plan which is not ACA-compliant as
an alternative to, or a substitute for, a health benefit plan which meets
federal and state requirements under the ACA.
C.
Summary of Benefits and Coverage (SBC)
1.
The SBC form and the Colorado Supplement to the Summary of Benefits
and Coverage form must be in compliance with the requirements of state
and federal law, and Colorado Insurance Regulation 4-2-20.
2.
The SBC must contain, in plain language, simple and consistent
information about the benefits and coverage of the stated health benefit
plan as specified in 45 C.F.R. § 147.200(a).
2.
If upon review the Division finds that an SBC or the Colorado Supplement
to the Summary of Benefits form is misleading, deceptive, or
misrepresentative of the benefits in the stated health benefit plan, the
submitting insurer may be found to have violated the marketing standards
found at § 10-3-1104, C.R.S.
Section 10 Testimonials or Endorsements by Third Parties
A.
Testimonials and/or endorsements used in advertisements shall be genuine,
represent the current opinion of the author, be applicable to the policy advertised
and be accurately reproduced. The insurer, in using a testimonial or
endorsement, makes as its own all of the statements contained in it, and the
advertisement, including the statement, is subject to all of the provisions of this
regulation. When a testimonial or endorsement is used more than one (1) year
after it was originally given, a confirmation must be obtained.
B.
A person shall be deemed a “spokesperson” if the person making the testimonial
or endorsement:
1.
Has a financial interest in the insurer or a related entity as a stockholder,
director, officer, employee or otherwise;
2.
Has been formed by the insurer, is owned or controlled by the insurer, its
employees, or the person or persons who own or control the insurer;
3.
Has any person in a policy-making position who is affiliated with the
insurer in any of the above described capacities; or
4.
Is in any way directly or indirectly compensated for making a testimonial or
endorsement.
C.
Any person or agency acting as a spokesperson, as defined in Section 10.B.,
who performs any of the following acts in an advertisement shall be considered
soliciting an insurance product, and such person or agency shall be a licensed
insurance producer or agency pursuant to Colorado insurance law:
1.
Individual who solicits, negotiates, effects, procures, delivers, renews,
continues or binds; or
2.
A corporation, partnership, association, or other legal entity transacting the
business of insurance.
D.
The fact of a financial interest or the proprietary or representative capacity of a
spokesperson shall be disclosed in an advertisement and shall be accomplished
in the introductory portion of the testimonial or endorsement in the same form
and with equal prominence. If a spokesperson is directly or indirectly
compensated for making a testimonial or endorsement, the fact shall be
disclosed in the advertisement. The requirement of this disclosure may be fulfilled
by use of the phrase “Paid Endorsement” or words of similar import in a type
style and size at least equal to that used for the spokesperson’s name or the
body of the testimonial or endorsement, whichever is larger. In the case of
television or radio advertising, the required disclosure shall be accomplished in
the introductory portion of the advertisement and shall be given prominence.
E.
The disclosure requirements of this regulation shall not apply where the sole
financial interest or compensation of a spokesperson, for all testimonials or
endorsements made on behalf of the insurer, consists of the payment of union
scale wages required by union rules, and if the payment is actually the scale for
TV or radio performances.
F.
An advertisement shall not state or imply that an insurer or an accident and
sickness insurance policy has been approved or endorsed by any individual,
group of individuals, society, association or other organizations, unless that is the
fact, and unless any proprietary relationship between an organization and the
insurer is disclosed. If the entity making the endorsement or testimonial has been
formed by the insurer or is owned or controlled by the insurer or the person or
persons who own or control the insurer, the fact shall be disclosed in the
advertisement. If the insurer or an officer of the insurer formed or controls the
association, or holds any policy-making position in the association, that fact must
be disclosed.
G.
When a testimonial refers to benefits received under an accident and sickness
insurance policy, the specific claim data, including claim number, date of loss and
other pertinent information shall be retained by the insurer for inspection for a
period of four (4) years or until the filing of the next regular report of examination
of the insurer, whichever is the longer period of time. The use of testimonials that
do not correctly reflect the present practices of the insurer or that are not
applicable to the policy or benefit being advertised is not permissible.
Section 11 Use of Statistics
A.
An advertisement relating to the dollar amounts of claims paid, the number of
persons insured, or similar statistical information relating to an insurer or policy
shall not use irrelevant facts, and shall not be used unless it accurately reflects
all of the current and relevant facts. The advertisement shall not imply that the
statistics are derived from the policy advertised unless that is the fact, and when
applicable to other policies or plans, shall specifically so state.
1.
An advertisement shall specifically identify the accident and sickness
insurance policy to which statistics relate and where statistics are given
that are applicable to a different policy, it shall be stated clearly that the
data does not relate to the policy being advertised.
2.
An advertisement using statistics that describe an insurer, such as assets,
corporate structure, financial standing, age, product lines or relative
position in the insurance business, may be irrelevant and, if used at all,
shall be used with extreme caution because of the potential for misleading
the public. As a specific example, an advertisement for accident and
sickness insurance that refers to the amount of life insurance which the
insurer has in force or the amounts paid out in life insurance benefits is not
permissible unless the advertisement clearly indicates the amount paid out
for each line of insurance.
B.
An advertisement shall not represent or imply that claim settlements by the
insurer are “liberal” or “generous”, or use words of similar import, or that claim
settlements are or will be beyond the actual terms of the contract. An unusual
amount paid for a unique claim for the policy advertised is misleading and shall
not be used.
C.
The source of any statistics used in an advertisement shall be identified in the
advertisement.
Section 12 Identification of Plan or Number of Policies
A.
An advertisement that uses the word “plan” without prominently identifying it as
an accident and sickness insurance policy is prohibited.
B.
When a choice of the amount of benefits is referred to, an advertisement that is
an invitation to contract shall disclose that the amount of benefits provided
depends upon the plan selected and that the premium will vary with the amount
of the benefits selected.
C.
When an advertisement that is an invitation to contract refers to various benefits
that may be contained in two (2) or more policies, other than group master
policies, the advertisement shall disclose that the benefits are provided only
through a combination of policies.
Section 13 Disparaging Comparisons and Statements
An advertisement shall not directly or indirectly make unfair or incomplete comparisons
of policies or benefits or comparisons of non-comparable policies of other insurers, and
shall not disparage competitors, their policies, services or business methods, and shall
not disparage or unfairly minimize competing methods of marketing insurance.
A.
An advertisement shall not contain statements such as “no red tape” or “here is
all you do to receive benefits”.
B.
Advertisements that state or imply that competing insurance coverages
customarily contain certain exceptions, reductions or limitations not contained in
the advertised policies are prohibited unless the exceptions, reductions or
limitations are contained in a substantial majority of the competing coverages.
C.
Advertisements that state or imply that an insurer’s premiums are lower or that its
loss ratios are higher because its organizational structure differs from that of
competing insurers are prohibited.
Section 14 Jurisdictional Licensing and Status of Insurer
A.
An advertisement that is intended to be seen or heard beyond the limits of the
jurisdiction in which the insurer is licensed shall not imply licensing beyond those
limits.
B.
An advertisement shall not create the impression directly or indirectly that the
insurer, its financial condition or status, or the payment of its claims, or the
merits, desirability, or advisability of its policy forms or kinds of plans of insurance
are approved, endorsed or accredited by any division or agency of the state or
the federal government. Terms such as “official” or words of similar import, used
to describe any policy or application form are prohibited because of the potential
for deceiving or misleading the public.
C.
An advertisement shall not imply that approval, endorsement or accreditation of
policy forms or advertising has been granted by any division or agency of the
state or federal government. Approval of either policy forms or advertising shall
not be used by an insurer to imply or state that a governmental agency has
endorsed or recommended the insurer, its policies, advertising or its financial
condition.
D.
For purposes of Section 14 and the multistate plan provisions of the ACA, a
contract between the Office of Personal Management and a multistate insurer
does not constitute approval, endorsement or accreditation by the federal
government.
Section 15 Identity of Insurer
A.
The name of the actual insurer shall be stated in all of its advertisements. The
form number or numbers of the policy advertised shall be stated in an
advertisement that is an invitation to contract. An advertisement shall not use a
trade name, an insurance group designation, name of the parent company of the
insurer, name of a particular division of the insurer, service mark, slogan, symbol
or other device that without disclosing the name of the actual insurer, would have
the capacity and tendency to mislead or deceive as to the true identity of the
insurer.
B.
An advertisement shall not use any combination of words, symbols, or physical
materials that by their content, phraseology, shape, color or other characteristics
are so similar to combination of words, symbols or physical materials used by
agencies of the federal government or of this state, or otherwise appear to be of
such a nature that it tends to confuse or mislead prospective insureds into
believing that the solicitation is in some manner connected with an agency of the
municipal, state or federal government.
C.
Advertisements, envelopes or stationery that employ words, letters, initials,
symbols or other devices that are similar to those used in governmental agencies
or by other insurers are not permitted if they may lead the public to believe:
1.
That the advertised coverages are somehow provided by or are endorsed
by the governmental agencies or the other insurers; or
2.
That the advertiser is the same as is connected with or is endorsed by the
governmental agencies or the other insurers.
D.
An advertisement shall not use the name of a state or political subdivision of a
state in a policy name or description.
E.
An advertisement in the form of envelopes or stationery of any kind may not use
any name, service mark, slogan, symbol or any device in a manner that implies
that the insurer or the policy advertised, or that any producer who may call upon
the consumer in response to the advertisement, is connected with a
governmental agency, such as the Social Security Administration.
F.
An advertisement may not incorporate the word “Medicare” in the title of the plan
or policy being advertised unless, wherever it appears, the word is qualified by
language differentiating it from Medicare. The advertisement, however, shall not
use the phrase “[ ] Medicare Department of the [ ] Insurance Company”, or
language of similar import.
G.
An advertisement may not imply that the reader may lose a right or privilege or
benefit under federal, state or local law if he or she fails to respond to the
advertisement.
H.
The use of letters, initials or symbols of the corporate name or trademark that
would have the tendency or capacity to mislead or deceive the public as to the
true identity of the insurer is prohibited unless the true, correct and complete
name of the insurer is in close conjunction and in the same size type as the
letters, initials or symbols of the corporate name or trademark.
I.
The use of the name of an agency or “[ ] Underwriters” or “[ ] Plan” in type, size
and location so as to have the capacity and tendency to mislead or deceive as to
the true identity of the insurer is prohibited.
J.
The use of an address so as to mislead or deceive as to true identity of the
insurer, its location or licensing status is prohibited.
K.
An insurer shall not use, in the trade name of its insurance policy, any
terminology or words so similar to the name of a governmental agency or
governmental program as to have the tendency to confuse, deceive or mislead
the prospective purchaser.
L.
Advertisements used by producers of an insurer shall have prior written approval
of the insurer before they may be used.
M.
A producer who makes contact with a consumer, as a result of acquiring that
consumer’s name from a lead-generating device, shall disclose that fact in the
initial contact with the consumer. A producer or insurer may not use names
produced from lead-generating devices that do not comply with the requirements
of this regulation.
Section 16 Group or Quasi-Group Implications
A.
An advertisement of a particular policy shall not state or imply that prospective
insureds become group or quasi-group members covered under a group policy
and as members, enjoy special rates or underwriting privileges, unless that is the
fact.
B.
This regulation prohibits the solicitations of a particular class, such as
governmental employees, by use of advertisements which state or imply that
their occupational status entitles them to reduced rates on a group or other basis
when, in fact, the policy being advertised is sold only on an individual basis at
regular rates.
C.
Advertisements that indicate that a particular coverage or policy is exclusively for
“preferred risks” or a particular segment of the population or that a particular
segment of the population is an acceptable risk, when the distinctions are not
maintained in the issuance of policies, are prohibited.
D.
An advertisement to join an association, trust or discretionary group that is also
an invitation to contract for insurance coverage shall clearly disclose that the
applicant will be purchasing both membership in the association, trust or
discretionary group and insurance coverage. The insurer shall solicit insurance
coverage on a separate and distinct application that requires a separate
signature. The separate and distinct applications required need not be on
separate documents or contained in a separate mailing. The insurance program
shall be presented so as not to conceal the fact that the prospective members
are purchasing insurance as well as applying for membership, if that is the case.
Similarly, it is prohibited to use terms such as “enroll” or “join” to imply group or
blanket insurance coverage when that is not the fact.
E.
Advertisements for group or franchise group plans that provide a common benefit
or a common combination of benefits shall not imply that the insurance coverage
is tailored or designed specifically for that group, unless that is the fact.
Section 17 Introductory, Initial or Special Offers
A.
An advertisement of an individual policy shall not directly or by implication
represent that a contract or combination of contracts is an introductory, initial or
special offer, or that applicants will receive substantial advantages not available
at a later date, or that the offer is available only to a specified group of
individuals, unless that is the fact. An advertisement shall not contain phrases
describing an enrollment period as “special”, “limited”, or similar words or
phrases when the insurer uses the enrollment periods as the usual method of
marketing accident and sickness insurance.
B.
This regulation prohibits any statement or implication to the effect that only a
specific number of policies will be sold, or that a time is fixed for the
discontinuance of the sale of the particular policy advertised because of special
advantages available in the policy, unless that is the fact.
C.
An advertisement shall not offer a policy that utilizes a reduced initial premium
rate in a manner that overemphasizes the availability and the amount of the initial
reduced premium. When an insurer charges an initial premium that differs in
amount from the amount of the renewal premium payable on the same mode, the
advertisement shall not display the amount of the reduced initial premium either
more frequently or more prominently than the renewal premium, and both the
initial reduced premium and the renewal premium must be stated in juxtaposition
in each portion of the advertisement where the initial reduced premium appears.
D.
Special awards, such as a “safe drivers’ award”, shall not be used in connection
with advertisements of accident and sickness insurance.
Section 18 Statements about an Insurer
An advertisement shall not contain statements that are untrue in fact, or by implication
misleading, with respect to the assets, corporate structure, financial standing, age or
relative position of the insurer in the insurance business. An advertisement shall not
contain a recommendation by any commercial rating system unless it clearly indicates
the purpose of the recommendation and the limitations of the scope and extent of the
recommendations.
Section 19 Enforcement Procedures
Each insurer shall maintain at its home or principal office a complete file containing
every printed, published or prepared advertisement of its individual policies and typical
printed, published or prepared advertisements of its blanket, franchise and group
policies hereafter disseminated in this or any other state, whether or not licensed in
another state, with a notation attached to each advertisement that indicates the manner
and extent of distribution and the form number of any policy advertised. The file shall be
subject to regular and periodical inspection by the Commissioner. All of these
advertisements shall be maintained in a file for a period of either four (4) years or until
the filing of the next regular report on examination of the insurer, whichever is the longer
period of time.
Section 20 Severability
If any provisions of this regulation or the application of it to any person or circumstances
is for any reason held to be invalid, the remainder of the regulation shall not be affected.
Section 21 Incorporated Materials
45 C.F.R. § 147.200(a) shall mean 45 C.F.R. § 147.200(a) as published on the effective
date of this regulation and does not include later amendments to or editions of 45 C.F.R.
§ 147.200(a). A copy of 45 C.F.R. § 147.200(a) may be examined during regular
business hours at the Colorado Division of Insurance, 1560 Broadway, Suite 850,
Denver, Colorado 80202. A certified copy of 45 C.F.R. § 147.200(a) may be requested
from the Colorado Division of Insurance, 1560 Broadway, Suite 850, Denver, Colorado
80202. A charge for certification or copies may apply. A copy may also be obtained
online at www.ecfr.gov.
Section 22 Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspensions or revocation of license, subject to the requirements of due
process.
Section 23 Effective Date
This regulation is effective May 15, 2026.
Section 24 History
Originally issued as Regulation 75-2, effective December 22, 1975.
Renumbered as Regulation 4-2-3, effective June 1, 1992.
Amended regulation, effective July 1, 1993.
Repealed and Repromulgated in full, effective February 1, 2001.
Amended regulation, effective August 1, 2001.
Amended regulation, effective February 1, 2003.
Amended regulation, effective May 1, 2010.
Amended regulation, effective October 1, 2013.
Amended regulation, effective April 15, 2014.
Amended regulation, effective February 1, 2020.
Amended regulation, effective May 15, 2026.
Regulation 4-2-5
[Repealed eff. 05/01/2010]
Regulation 4-2-6
CONCERNING THE DEFINITION OF THE TERM
“COMPLICATIONS OF PREGNANCY”
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Rules
Section 6
Severability
Section 7
Enforcement
Section 8
Effective Date
Section 9
History
Section 1
Authority
This amended regulation is promulgated and adopted by the Commissioner of
Insurance under the authority of §§ 10-1-109, 10-3-1110 and 10-16-109 and, C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to standardize the definition of the term “complications
of pregnancy” as used in sickness and accident insurance policies covering residents of
this state consistent with the commonly perceived connotation of this term by the
general public.
Section 3
Applicability
This regulation shall apply to all companies and entities marketing or selling sickness
and accident policies providing coverage for disability due to sickness issued by an
entity subject to the provisions of Part 2 of Article 16 of Title 10, and to those companies
and entities marketing or selling individual or group services or indemnity contracts
subject to the provisions of Part 3 of Article 16 of Title 10.
Section 4
Definitions
For the purposes of this regulation “complications of pregnancy” shall mean:
A.
Conditions (when the pregnancy is not terminated) whose diagnoses are distinct
from pregnancy but are adversely affected by pregnancy or are caused by
pregnancy, such as acute nephritis, nephrosis, cardiac decompensation, missed
abortion, and similar medical and surgical conditions of comparable severity, but
shall not include false labor, occasional spotting, physician-prescribed rest during
the period of pregnancy, morning sickness, hyperemesis gravidarum,
preeclampsia, and similar conditions associated with the management of a
difficult pregnancy not constituting a nosologically distinct complication of
pregnancy;
B.
Non-elective cesarean section, ectopic pregnancy, which is terminated, and
spontaneous termination of pregnancy, which occurs during a period of gestation
in which a viable birth is not possible.
Section 5
Rules
All companies marketing sickness and accident insurance policies, as defined in this
regulation, delivered or issued for delivery in the State of Colorado shall use in each
insurance policy or certificate of insurance a definition of the complications of pregnancy
no more restrictive than that required by this regulation, and must be in compliance with
the requirements found at § 10-16-104(2), C.R.S.
Section 6
Severability
If any provisions of this regulation or the application thereof to any person or
circumstance is for any reason held to be invalid, the remainder of the regulation shall
not be affected.
Section 7
Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspensions or revocation of license, subject to the requirements of due
process.
Section 8
Effective Date
This amended regulation shall become effective February 1, 2016.
Section 9
History
Originally issued as Regulation 78-16, effective June 30, 1979.
Amended Regulation 78-16, effective October 1, 1983.
Renumbered as Regulation 4-2-6, effective June 1, 1992.
Amended effective November 1, 2000.
Regulation amended, effective March 2, 2010.
Regulation amended effective February 1, 2016.
Regulation 4-2-8
CONCERNING REQUIRED HEALTH INSURANCE BENEFITS
FOR HOME HEALTH SERVICES AND HOSPICE CARE
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Requirements for Home Health Services
Section 6
Requirements for Hospice Care
Section 7
Additional Requirements for Home Health Services
Section 8
Severability
Section 9
Enforcement
Section 10
Effective Date
Section 11
History
Section 1
Authority
This regulation is promulgated and adopted by the Commissioner of Insurance under
the authority of § § 10-1-109 and 10-16-104(8)(d), C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to establish requirements for standard policy
provisions, which state clearly and completely the criteria for and extent of coverage for
home health services and hospice care and to facilitate prompt and informed decisions
regarding patient placement and discharge.
Section 3
Applicability
The requirements of this regulation shall apply to:
A.
Insurers subject to the provisions of Part 2 of Article 16 of Title 10, C.R.S. and
non-profit hospital, medical surgical, and health service corporations subject to
the provisions of Part 3 of Article 16 of Title 10, C.R.S., which provide: hospital,
surgical or major medical coverage on an expense incurred basis, except as
noted in paragraph B below, issued on or after the effective date hereof and to all
such policies renewed after said date, unless the insurer certifies in writing to the
Commissioner of Insurance that it no longer issues the type of policy being
renewed. “Renewed” or “renewal” means to continue coverage for an additional
policy period upon expiration of the current policy period of a policy.
B.
This regulation does not apply to the following:
1.
Medicare supplement policies issued under § 10-18-101 et seq., C.R.S.;
2.
Credit accident and health policies issued under § 10-10-101 et seq.,
C.R.S.;
3.
This regulation does not apply to health benefit plans as defined at § 10-
16-102(32), C.R.S.; and
4.
Any insurance policy, contract, or certificate which provides coverage
exclusively for:
a.
Disability loss of income;
b.
Dental services;
c.
Optical services;
d.
Hospital confinement indemnity;
e.
Accident only; or
f.
Prescription drug services.
Section 4
Definitions
A.
“Benefit period” means, for purposes of this regulation, a hospice care service
period of ninety (90) days, during which services are provided on a regular basis.
B.
“Bereavement” means, for purposes of this regulation, that period of time during
which survivors mourn a death and experience grief. Bereavement services
mean support services to be offered during the bereavement period.
C.
“Core services” means, for purposes of this regulation, nursing services, pastoral
services, trained volunteers, and psychosocial services routinely provided by
hospice staff or volunteers.
D.
“Evaluation” means, for purposes of this regulation, an objective, formal and
regular assessment of the functioning of the organization and of the provision of
hospice care.
E.
“Home care services” means, for purposes of this regulation, hospice services,
which are provided in the place the patient designates as his/her primary
residence, which may be a private residence, retirement community, assisted
living, nursing or Alzheimer facility.
F.
“Home health agency” means, for purposes of this regulation, an agency which
has been certified by the Colorado Department of Public Health and Environment
as meeting the provisions of Title XVIII of the Federal “Social Security Act”, as
amended, for licensed or certified home health agencies and which is engaged in
arranging and providing nursing services, home health aide services and other
therapeutic and related services.
G.
“Home health services” means, for purposes of this regulation, the following
services provided by a certified home health agency under a plan of care to
eligible persons in their place of residence:
1.
Skilled nursing services;
2.
Certified and licensed nurse aide services, as defined in § 12-38.1-102(3),
C.R.S.;
3.
Physical therapy, occupational therapy, or speech and language pathology
services, as such therapy and services are defined in § 12-43.7-101, et
seq, C.R.S.;
4.
Social Work Practice services, as defined in § 12-43-403,C.R.S., by a
licensed social worker. “Licensed Social Worker” shall have the same
meaning as provided in § 12-43-201(5.5), C.R.S.; and
5.
Medical supplies, equipment and appliances suitable for use in the home.
H.
“Home health visit” means, for purposes of this regulation, each visit by a
member of the home health team, provided on a part-time and intermittent basis
as included in the plan of care. Services of up to four (4) hours by a home health
aide shall be considered as one visit.
I.
“Homemaker services” means, for purposes of this regulation, services provided
to the patient, which include:
1.
General household activities including the preparation of meals and
routine household care; and
2.
Teaching, demonstrating and providing patient/family with household
management techniques that promote self-care, independent living and
good nutrition.
J.
“Hospice” means, for purposes of this regulation, a facility or service licensed by
the Department of Public Health and Environment under a centrally administered
program of palliative, supportive, and interdisciplinary team services providing
physical, psychosocial, spiritual, and bereavement care for terminally ill
individuals and their families to be available 24 hours, 7 days a week. Hospice
services shall be provided in the home, a hospice facility, and/or other licensed
health facility. Hospice services include but shall not necessarily be limited to the
following: nursing, physician, certified nurse aide, nursing services delegated to
other assistants, homemaker, physical therapy, pastoral counseling, trained
volunteer, and social services.
K.
“Hospice care” means, for purposes of this regulation, an alternative way of
caring for terminally ill individuals which stresses palliative care as opposed to
curative or restorative care. Hospice care focuses upon the patient/family as the
unit of care. Supportive services are offered to the family before and after the
death of the patient. Hospice care is not limited to medical intervention, but
addresses physical, psychosocial, and spiritual needs of the patient. Hospice
care is planned, implemented and evaluated by an interdisciplinary team of
professionals and volunteers.
L.
Hospice levels of care:
1.
“Routine home care” means, for purposes of this regulation, the level of
care a patient/family receives according to the interdisciplinary team's plan
of care each day the patient is at home and not receiving continuous
home care.
2.
“Continuous home care” means, for purposes of this regulation, the level
of care received by the patient during a period of medical crisis to achieve
palliation and management of acute medical symptoms. The
preponderance of care must be nursing care (at least half) and care must
be provided for a period of at least eight hours (need not be consecutive)
in one calendar day. Home health aide and homemaker services, or both,
may be provided to supplement nursing care.
3.
“Inpatient hospice respite care” means, for purposes of this regulation, the
level of care received when the patient is in a licensed facility to provide
the caregiver a period of relief. Inpatient respite care may be provided only
on an intermittent, non-routine, short-term basis. It may be limited to
periods of five days or less.
4.
“General inpatient hospice care” means, for purposes of this regulation,
the level of care the patient receives when short-term inpatient care for
pain control or acute symptom management cannot be achieved in the
home. This level of care must be provided in a licensed facility with the
approval of the physician and the hospice.
M.
“Hospice per diem rate” means, for purposes of this regulation, the
predetermined rate for each day in which an individual is enrolled in a hospice
program and under its care, without regard to which, if any, services are actually
provided on a specific day.
N.
“Inpatient hospice facility” means, for purposes of this regulation, a facility which
shall directly provide inpatient services and may provide any or all of the
continuum of hospice services as described in Section 4.E. These services are
provided twenty-four (24) hours a day and, to the extent possible, in a homelike
setting.
O.
“Inpatient services” means, for purposes of this regulation, hospice services
provided to patient/families who require twenty-four (24) hour nursing supervision
in a licensed hospice facility or other licensed health facility. In the event that a
hospice provides inpatient services in a licensed health facility other than a
hospice, such hospice shall maintain administrative control of and responsibility
for the provision of all hospice services.
P.
“Interdisciplinary team” means, for purposes of this regulation, a group of
qualified individuals, which shall include, but is not limited to, a physician,
registered nurse, clergy/counselors, social workers, volunteer director, and/or
trained volunteers, and appropriate staff who collectively have expertise in
meeting the special needs of hospice patient/families.
Q.
“Palliative services” means, for purposes of this regulation, those services and/or
interventions which are not curative but which produce the greatest degree of
relief from pain and other symptoms of the terminal illness.
R.
“Patient” means, for purposes of this regulation, an individual in the terminal
stage of illness who has an anticipated life expectancy of six (6) months or less
and who alone or in conjunction with a family member or members, has
voluntarily agreed to admission and been accepted into a hospice.
S.
“Patient/family” means, for purposes of this regulation, one unit of care consisting
of those individuals who are closely linked with the patient, including the
immediate family, the primary or designated care giver and individuals with
significant personal ties.
T.
“Personal care” means services provided to a patient in his or her home to meet
the patient's physical requirements and/or to accommodate a patient's
maintenance or supportive needs.
U.
“Unrelated illness” means, for purposes of this regulation, a diagnosed condition,
which is not a direct result of the terminal diagnosis or its treatment and the
expected course of that terminal illness.
Section 5
Requirements for Home Health Services
A.
General Policy Provisions Pertaining to Home Health Care.
1.
The policy offering shall provide that home health services are to be
covered when such services are necessary as alternatives to
hospitalization or in place of hospitalization. Prior hospitalization shall not
be required.
2.
The policy offering shall require, as a condition of coverage that home
health care services are to be rendered pursuant to a physician's written
order, under a plan of care established by the physician in collaboration
with a home health care provider.
3.
The policy offering may use case management requirements including, but
not limited to, authorization of benefits prior to the beginning of services
and review of treatment at periodic intervals.
4.
The policy may require that all home health services included in the plan
of care be coordinated by the home health agency.
B.
Benefits for Home Health Care Services.
1.
Benefit levels for home health care services shall not be less than the
deductible, coinsurance and stop loss provisions of the overall policy or
certificate.
2.
The policy or certificate may contain a limitation on the number of home
health visits, but no policy offered may provide for fewer than sixty (60)
home health visits in any calendar year.
3.
The policy offered shall include benefits for the following services:
a.
Skilled nursing services provided by a Registered or Licensed
Nurse;
b.
Certified nurse aide services;
c.
Physical therapy;
d.
Occupational therapy;
e.
Speech and language pathology;
f.
Respiratory and inhalation therapy;
g.
Nutrition counseling by a nutritionist or dietitian;
h.
Social work practice services;
i.
Medical supplies;
j.
Prosthesis and orthopedic appliances; and
k.
Rental or purchase of durable medical equipment.
4.
The services identified in subsections B.3.i. through B.3.l. of this section
may be included elsewhere in the policy, rather than specifically in the
home health benefit provisions.
C.
Limitations and Exclusions.
1.
Benefits for home health services may be governed by policy or certificate
limitations and exclusions, including but not limited to, exclusion for non-
skilled personal care and conditions for surgery excluded in the policy or
certificate.
2.
The following items need not be considered as eligible expenses under
home health care benefits:
a.
Services or supplies for personal comfort or convenience, including
homemaker services;
b.
Services related to well-baby care; and
c.
Food services or meals other than dietary counseling excluding
tube feedings.
Section 6
Requirements for Hospice Care
A.
General Provisions Pertaining to Hospice Care.
1.
The policy offering shall provide that hospice care services are to be
covered when such services are provided under active management
through a hospice which is responsible for coordinating all hospice care
services, regardless of the location or facility in which such services are
furnished.
2.
The policy offering shall provide that benefits are allowed only for
individuals who are terminally ill and have a life expectancy of six (6)
months or less, except that benefits may exceed six (6) months should the
patient continue to live beyond the prognosis for life expectancy, in which
case the benefits shall continue at the same rate for one additional benefit
period. After the exhaustion of three benefit periods, the insurer's case
management staff shall work with the individual's attending physician and
the hospice's Medical Director to determine the appropriateness of
continuing hospice care.
3.
The policy offering shall require a physician's certification of the patient's
illness, including a prognosis for life expectancy and the appropriateness
for hospice care. The insurer may also require a copy of the patient’s plan
of care and any changes made to the level of care or to the plan of care.
4.
The policy offering may use case management requirements including, but
not limited to, authorization of benefits prior to the beginning of services
and review of care at periodic intervals.
5.
The policy offering shall clearly indicate that services and charges incurred
in connection with an unrelated illness will be processed in accordance
with policy coverage provisions applicable to all other illnesses and/or
injuries.
B.
Benefits for Hospice Care Services.
1.
Benefits for hospice care services shall be governed by the deductible,
coinsurance and stop-loss provisions of the overall policy or certificate.
The details of these provisions will be forwarded and updated to the
provider upon authorization of benefits.
2.
The policy or certificate may contain a dollar limitation on routine home
care hospice benefits. Other services provided by or through the hospice
that are available to the insured will be negotiated at a hospice per diem
rate with the hospice provider. Any policy offered shall provide a benefit of
no less than $150 per day for any combination of the following routine
home care services, which are planned, implemented and evaluated by
the interdisciplinary team:
a.
Intermittent and twenty-four (24) hour on-call professional nursing
services provided by or under the supervision of a Registered
Nurse;
b.
Intermittent and twenty-four (24) hour on-call social/counseling
services: and;
c.
Certified nurse aide services or nursing services delegated to other
persons pursuant to § 12-38-132, C.R.S.
The total benefit for each benefit period for these services shall not
be less than the per diem benefit multiplied by ninety (90) days.
3.
The policy offering shall include the following benefits, subject to the
policy's deductible, coinsurance and stoploss provisions, which are
exclusive of and shall not be included in the dollar limitation for hospice
care benefits as specified in (2) above:
a.
Bereavement support services for the family of the deceased
person during the twelve month period following death, and in no
event shall this maximum benefit be less than $1400.
b.
Short-term general inpatient (acute) hospice care or continuous
home care which may be required during a period of crisis, for pain
control or symptom management and shall be paid consistent with
any other sickness or illness (i.e., not included in the per diem
limitation specified in subsection 2 of this section). Such care shall
require prior authorization of the interdisciplinary team and may,
except for emergencies, weekends or holidays, require prior
authorization by the insurer, provided, however, that the insurer
may not require prior authorization when the transfer to the higher
level of care was necessary during the insurer’s non-business
hours if the hospice seeks the authorization during the insurer’s first
business day;
c.
Medical supplies;
d.
Drugs and biologicals;
e.
Prosthesis and orthopedic appliances;
f.
Oxygen and respiratory supplies;
g.
Diagnostic testing;
h.
Rental or purchase of durable equipment;
i.
Transportation;
j.
Physicians services;
k.
Therapies including physical, occupational and speech; and
l.
Nutritional counseling by a nutritionist or dietitian.
C.
Limitations and Exclusions.
Benefits for hospice care services shall be governed by policy or certificate limitations
and exclusions, to the extent that such policy or certificate is not in conflict with the
statutory mandate that hospice care be offered with the minimum benefits required by
this regulation. The insurer must notify the hospice in writing of any such limitation of
benefits, and must do so within two business days of a request to determine if specific
services are excluded or authorized under the coverage.
Section 7
Additional Requirements for Home Health Care Services and Hospice
Care
A.
The offer to a policyholder to purchase home health care and hospice care
coverage must be in writing, either by means of a prominent statement or
question on the application for the policy or on a separate form.
B.
Nothing in this regulation shall prohibit the insurer from offering a higher level of
benefits than required herein.
Section 8
Severability
If any provision of this regulation or the application of it to any person or circumstance is
for any reason held to be invalid, the remainder of the regulation shall not be affected.
Section 9
Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspension or revocation of license, subject to the requirements of due
process.
Section 10 Effective Date
The effective date of this regulation is January 1, 2014.
Section 11 History
Originally issued as Colorado Regulation 85-6, effective Oct 1, 1985.
Amended October 1, 1986.
Renumbered as Colorado Regulation 4-2-8, July 1, 1992.
Amended August 1, 1993.
Amended February 1, 1994.
Amended February 1, 2001.
Amended regulation, effective March 2, 2011.
Amended regulation, effective January 1, 2014.
Regulation 4-2-9
CONCERNING NON-DISCRIMINATORY TREATMENT OF
ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) AND HUMAN
IMMUNODEFICIENCY VIRUS (HIV) RELATED ILLNESS BY LIFE AND HEALTH
CARRIERS
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Rules
Section 6
Severability
Section 7
Incorporated Materials
Section 8
Enforcement
Section 9
Effective Date
Section 10
History
Appendix A FDA Licensed/Approved HIV Tests
Section 1
Authority
This amended regulation is promulgated and adopted by the Commissioner of
Insurance under the authority of § § 10-1-109, 10-3-1104.5(3)(d)(II) and 10-3-1110,
C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to establish standards that will assure non-
discriminatory treatment with respect to AIDS and HIV infection in underwriting
practices, policy forms and benefit provisions utilized by entities subject to the
provisions of this regulation. It also establishes what HIV/AIDS medical tests, permitted
under § 10-3-1104.5, C.R.S., are considered medically reliable for underwriting
decisions.
Section 3
Applicability
This regulation applies to all entities that provide life or a policy of sickness and accident
insurance in this state including a franchise insurance plan, a fraternal benefit society, a
health maintenance organization, a nonprofit hospital and health service corporation, a
sickness and accident insurance company, a life or annuity company, and any other
entity providing a life policy, annuity, or a policy of sickness and accident insurance
subject to the insurance laws and regulations of Colorado.
Section 4
Definitions
A.
“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.
B.
“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),
C.R.S.
C.
“Insurance coverage” shall mean life insurance policies, annuities, policies of
sickness and accident insurance, and other coverage that is not a health benefit
plan.
D.
“Person” shall have the same meaning as found at § 10-3-1104.5(2)(f), C.R.S.
E.
“Policy of sickness and accident insurance” shall have the same meaning as
found at §10-16-102(50), C.R.S.
Section 5
Rules
A.
No person, their agent or employee shall make any inquiry or investigation to
determine an insurance applicant's sexual orientation.
B.
Sexual orientation may not be used in the underwriting process or in the
determination of insurability.
C.
Insurance support organizations shall be directed by insurers and carriers to not
investigate, directly or indirectly, the sexual orientation of an applicant or a
beneficiary. All persons shall give written notice to their agents and employees
who conduct investigations of applicants for insurance coverage, that they shall
not investigate, either directly or indirectly, the sexual orientation of an applicant
or beneficiary.
D.
No question shall be used which is designed to establish the sexual orientation of
the applicant.
E.
Questions relating to the applicant having or having been diagnosed as having
AIDS or HIV infection are permissible if they are designed solely to establish the
existence of the condition. For example, straightforward questions on
applications are acceptable, such as, “Have you had or been told by a member of
the medical profession that you have AIDS or HIV infection?” or “Have you
received treatment from a member of the medical profession for AIDS or HIV
infection?” are acceptable.
F.
Questions relating to medical and other factual matters intending to reveal the
possible existence of a medical condition are permissible if they are not used as
a proxy to establish the sexual orientation of the applicant, and the applicant has
been given an opportunity to provide an explanation for any affirmative answers
given in the application. For example: “Have you had chronic cough, significant
weight loss, chronic fatigue, diarrhea, enlarged glands?” These types of
questions should be related to a finite period of time preceding completion of the
application and should be specific. Such questions should provide the applicant
the opportunity to give a detailed explanation.
G.
Persons may not use an applicant's marital status, living arrangements,
occupation, gender, medical history, beneficiary designation, or zip code or other
territorial classification to establish, or aid in establishing, the applicant's sexual
orientation.
H.
For the purpose of rating an applicant for health and life insurance, a person may
impose territorial rates only if the rates are based on sound actuarial principles or
are related to actual or reasonably anticipated experience.
I.
No adverse underwriting decision shall be made because medical records or any
investigation or report indicates that the applicant has demonstrated AIDS or HIV
infection related concerns by seeking counseling from health care professionals.
Neither shall an adverse underwriting decision be made on the basis of such
AIDS or HIV infection related concerns unless a medical test which is a reliable
predictor of infection, as defined in subsection J. of this section, has been
administered. This subsection does not apply to an applicant seeking treatment
and/or diagnosis.
J.
Reliable predictors of infection are delineated in § 10-3-1104.5(3)(d)(I), C.R.S.
Pursuant to § 10-3-1104.5(3)(d)(II), C.R.S., the Commissioner designates the
following tests, approved by the Colorado Department of Public Health and
Environment, as equally reliable predictors of AIDS or HIV infection:
1.
A positive HIV-1 p24 antigen test, as defined by the U.S. Department of
Public Health and Human Services, Center for Disease Control and
Prevention (The Morbidity and Mortality Weekly Report, Volume 95, March
1, 1996).
2.
A positive licensed polymerase chain reaction assay for HIV levels in the
serum.
3.
Two positive or repeatedly reactive commercially licensed serum, oral fluid
or urine ELISA or EIA tests and either:
a.
For serum or oral fluid specimens, a Western Blot test with bands
present at any two of p24, gp41 or gp120/gp160;
b.
for urine specimens, a Western Blot test with bands present at
gp160, or
c.
for serum specimens, a positive HIV 1/2 Multispot test.
K.
To be used for issuing or underwriting a policy, a test described in subsection J.
of this section must have been licensed by the U.S. Food and Drug
Administration as of the effective date of this regulation. A list of such tests is
attached as Appendix A.
L.
If a specific test licensed by the U.S. Food and Drug Administration indicates the
presence of the HIV infection or medical condition indicative of the HIV infection,
the person shall, before relying on a single test result to deny or limit coverage or
to rate the coverage, follow the U.S. Food and Drug Administration confirmation
protocols licensed as of the effective date of this regulation and shall use any
applicable confirmatory tests or series of tests licensed as of the effective date of
this regulation by the U.S. Food and Drug Administration to confirm the
indication. The confirmation protocols and applicable follow-up test regimens are
attached as Appendix A.
M.
If an applicant is required to take an AIDS or HIV infection test in connection with
an application for life or health insurance, the use of such test must be revealed
to the applicant and his or her written consent obtained. Test results shall be
strictly confidential medical information. However, this regulation is not intended
nor should it be interpreted as prohibiting reporting HIV infection to state and
local departments of health as provided in § § 25-4-1402 and 25-4-1403, C.R.S.
N.
Persons subject to this regulation may include questions on applications as to
whether or not the applicant has tested positive on an AIDS or HIV infection test.
However, in the event of an affirmative response, no adverse underwriting
decisions shall be made on the basis of such response unless it can be
determined that the test protocols in subsections J. and K. of this section above,
have been followed.
O.
Insurance coverage which excludes or limits coverages for expenses related to
the treatment of AIDS and HIV related illness or complications of AIDS, e.g.,
opportunistic infection resulting from AIDS, shall not be issued for use in
Colorado, except to the extent that such exclusions or limitations are consistent
with the exclusions or limitations applicable to other covered illnesses or
conditions covered by the policy or certificate.
Section 6
Severability
If any provision of this regulation or the application thereof to any person or
circumstance is for any reason held to be invalid, the remainder of this regulation shall
not be affected.
Section 7
Incorporated Materials
The Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 published by
U.S. Department of Public Health and Human Services, Center for Disease Control and
Prevention shall mean Morbidity and Mortality Weekly Report, Volume 95, March 1,
1996 as published on the effective date of this regulation and does not include later
amendments to or editions of Morbidity and Mortality Weekly Report, Volume 95, March
1, 1996. A copy of the Morbidity and Mortality Weekly Report, Volume 95, March 1,
1996 may be examined during regular business hours at the Colorado Division of
Insurance, 1560 Broadway, Suite 850, Denver, Colorado, 80202. A certified copy of
Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 may be requested
from Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333.
A charge for certification or copies may apply.
A copy of the Morbidity and Mortality Weekly Report, Volume 95, March 1, 1996 may be
examined at any state publications depository library.
Section 8
Enforcement
Noncompliance with this regulation may result in the imposition of any of the sanctions
made available in the Colorado statutes pertaining to the business of insurance, or other
laws, which include the imposition of civil penalties, issuance of cease and desist
orders, and/or suspensions or revocation of license, subject to the requirements of due
process.
Section 9
Effective Date
This regulation as amended is effective November 15, 2013.
Section 10 History
Originally issued as Regulation 87-2, effective January 1, 1988.
Renumbered as Regulation 4-2-9, effective June 1, 1992.
Amended Section IV(J), effective February 1, 1995.
Amended Regulation, effective March 2, 1999.
Amended Regulation, effective May 1, 2010.
Amended Regulation, effective July 1, 2012.
Amended Regulation effective November 15, 2013.
Appendix A
FDA Licensed/Approved HIV Tests for Colorado Regulation 4-2-9
Published as of 7/16/2013
Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
GS rLAV EIA
HIV-1 EIA
Serum /
Plasma
Donor Screen
(serum/plasm
a). Diagnostic
(Dried blood
spot).
Bio-Rad
Laboratories
Redmond,
WA US
License 1109
6/29/1998 BL102866/1031,
BL102866/1032
Fluorognost HIV-1
IFA
HIV-1 IFA
Serum /
Plasma
Donor
Supplemental.
Donor Screen
(Only in
special
cases).
Sanochemia
Pharmazeutik
a AG Vienna,
Austria US
License 1631
2/5/1992 BL103288/0
Cambridge Biotech
HIV-1 Western Blot
Kit
HIV-1 WB
Serum /
Plasma
Donor
Supplemental.
Diagnostic
supplemental.
Maxim
Biomedical,
Inc. Rockville,
MD US
License 1741
2/25/1999 BL103843
GS HIV-1 Western
Blot
HIV-1 WB
Serum /
Plasma
Donor
Supplemental
Bio-Rad
Laboratories
Redmond,
WA US
License 1109
11/13/199
8
BL103655/0
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
Avioq HIV-1
Microelisa System HIV-1 EIA
Serum,
Plasma,
Dried
blood
spot,
Oral
Fluid
Diagnostic:
For the
qualitative
detection of
antibodies to
Human
Immunodefici
ency Virus
Type 1 (HIV-1)
in human
specimens
collected as
serum,
plasma, dried
blood spots,
or oral fluid
specimens
obtained with
OraSure®.HIV
-1 Oral
Specimen
Collection
Device
Avioq Inc.,
Rockville, MD 9/21/2009 BP090022/0
HIVAB HIV-1 EIA HIV-1 EIA
Dried
Blood
Spot
Diagnostic
Abbott
Laboratories
Abbott Park,
IL US License
0043
4/22/1992 BL103404/0
Maxim Biotech
HIV-1 Urine EIA
HIV-1 EIA
Urine
Diagnostic
Maxim
Biomedical,
Inc. Rockville,
MD US
License 1741
1/3/1991 BP000009
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
INSTI™ HIV-1
Antibody Test Kit
HIV-1
Rapid
Immuno
assay
Plasma
/ Whole
Blood
(venipu
ncture
and
finger
stick)
Diagnostic:
For the
detection of
antibodies to
Human
Immunodefici
ency Virus
Type 1 (HIV-1)
in human
venipuncture
whole blood,
finger stick
blood, or
plasma
specimens.
bioLytical
Laboratories
Inc. British
Columbia,
Canada V6V
2X7
11/29/201
0
BP090032/0
Reveal Rapid HIV-
1 Antibody Test15 HIV-1
Rapid
Immuno
assay
Serum /
Plasma Diagnostic
MedMira
Laboratories,
Inc. Halifax,
Nova Scotia
Canada B3S
1B3
4/16/2003 BP000023/0
Uni-Gold
Recombigen HIV HIV-1
Rapid
Immuno
assay
Serum /
Plasma
/ Whole
Blood
(venipu
ncture
and
finger
stick)
Diagnostic
Trinity
Biotech, plc
Bray Co.,
Wicklow,
Ireland
12/23/200
3
BP030025/0
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
GS HIV-1 Western
Blot
HIV-1 WB
Dried
Blood
Spot
Diagnostic
Supplemental
Bio-Rad
Laboratories
Redmond,
WA US
License 1109
11/13/199
8
BL103655/0
Fluorognost HIV-1
IFA
HIV-1 IFA
Dried
Blood
Spot
Diagnostic
Supplemental
Sanochemia
Pharmazeutik
a AG Vienna,
Austria US
License 1631
5/14/1996 BL103651/0
OraSure HIV-1
Western Blot Kit
HIV-1 WB
Oral
Fluid
Diagnostic
Supplemental
OraSure
Technologies
Bethlehem,
PA
6/3/1996 BP950004/0
Cambridge Biotech
HIV-1 Western Blot
Kit
HIV-1 WB
Urine
Diagnostic
Supplemental
Maxim
Biomedical,
Inc. Rockville,
MD US
License 1741
6/21/2001 BP010009/0
Human Immunodeficiency Virus Type 1 (HIV-1 Nucleic Acid Assay) - see Multiplex
Assays also, below
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
Human
Immunodeficienc
y Virus, Type 1
(HIV-1) Reverse
Transcription
(RT) Polymerase
Chain Reaction
(PCR) Assay
HIV-1 PCR
Plasma
Donor
Screen:
Qualitative
detection of
HIV-1
ribonucleic
acid (RNA) in
pools of
human
Source
Plasma
comprised of
equal aliquots
of not more
than 512
individual
plasma
samples.
BioLife
Plasma
Services,
L.P.
Deerfield, IL
US License
1640
1/31/200
7
BL125100/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
UltraQual HIV-1
RT-PCR Assay
HIV-1 PCR
Plasma
Donor
Screen:
Qualitative
detection of
HIV-1
ribonucleic
acid (RNA) in
pools of
human
Source
Plasma
comprised of
equal aliquots
of not more
than 512
individual
plasma
samples.
National
Genetics
Institute Los
Angeles, CA
US License
1582
9/18/200
1
BL103902/0
COBAS
Ampliscreen HIV-
1 Test
HIV-1 PCR
Plasma/
Cadaveric
serum or
plasma
Donor Screen
Expanded
Indications
For Use:
Source
Plasma
donors, other
living donors,
and organ
donors
Roche
Molecular
Systems,
Inc.
Pleasanton,
CA US
License
1636
12/20/20
02
BL125059/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
APTIMA HIV-1
RNA Qualitative
Assay
HIV-1
HIV-1
Nucleic
Acid
(TMA)
Plasma/
Serum
Diagnostic:
For use as an
aid in
diagnosis of
HIV-1
infection,
including
acute or
primary
infection.
Gen-Probe,
Inc., San
Diego, CA
US License
1592
10/4/200
6
BL103966/504
0
Abbott RealTime
HIV-1
Amplification Kit
HIV-1 PCR
Plasma
Patient
Monitoring:
Quantitation
of Human
Immunodefici
ency Virus
type 1 (HIV-
1) on the
automated
m2000
System. Not
intended to
be used as a
donor
screening test
or as a
diagnostic
test to confirm
the presence
of HIV-1
infection.
ABBOTT
Molecular,
Inc., Des
Plaines, IL
5/11/2007 BP060002/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
Roche Amplicor
HIV-1 Monitor
Test
HIV-1 PCR
Plasma
Patient
Monitoring:
Quantitation
of Human
Immunodefici
ency Virus
Type 1 (HIV-
1) nucleic
acid. Not
intended as a
donor
screening test
or as a
diagnostic
test to confirm
the presence
of HIV-1
infection.
Roche
Molecular
Systems,
Inc.
Pleasanton,
CA US
License
1636
3/2/1999 BP950005/004
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
COBAS
AmpliPrep/COBA
S TaqMan HIV-1
Test
HIV-1 PCR
Plasma
Patient
Monitoring:
Quantitation
of Human
Immunodefici
ency Virus
Type 1 (HIV-
1) nucleic
acid. Not
intended to
be used as a
donor
screening test
or as a
diagnostic
test to confirm
the presence
of HIV-1
infection.
Roche
Molecular
Systems,
Inc.
Pleasanton,
CA US
License
1636
5/11/2007 BP050069/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
Versant HIV-1
RNA 3.0 (bDNA) HIV-1
Signal
amplifi
cation
nucleic
acid
probe
Plasma
Patient
Monitoring:
Quantitation
of Human
Immunodefici
ency Virus
Type 1 (HIV-
1) nucleic
acid. Not
intended to
be used as a
donor
screening test
or as a
diagnostic
test to confirm
the presence
of HIV-1
infection.
Siemens
Healthcare
Diagnostics,
Inc.
9/11/2002 BP000028/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
ViroSeq HIV-1
Genotyping
System with the
3700 Genetic
Analyzer
HIV-1
HIV-1
Genoty
ping
Plasma
Patient
Monitoring:
For detecting
HIV genomic
mutations (in
the protease
and part of
the reverse
transcriptase
regions of
HIV) that
confer
resistance to
specific types
of
antiretroviral
drugs, as an
aid in
monitoring
and treating
HIV infection.
Celera
Diagnostics
Alameda,
CA
6/11/2003 BK030033/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agent
Forma
t
Current
Sample
Use
Manufactur
er
Approval
Date
STN
Trugene HIV-1
Genotyping Kit
and Open Gene
DNA Sequencing
System
HIV-1
HIV-1
Genoty
ping
Plasma
Patient
Monitoring:
For detecting
HIV genomic
mutations (in
the protease
and part of
the reverse
transcriptase
regions of
HIV) that
confer
resistance to
specific types
of
antiretroviral
drugs, as an
aid in
monitoring
and treating
HIV infection.
Siemens
Healthcare
Diagnostics,
Inc.
4/24/200
2
BK020005,
BK090077,
BK080073
Anti-HIV-1 Testing Service
Trade
name(s)
(Labeling
may be
out of
date)
Infec-
tious
Agent
Format Current
Sample
Use
ManufacturerApproval
Date
STN
Home
Access
HIV-1 Test
System
HIV-1
Dried
Blood
Spot
Collection
Device
Dried
Blood
Spot
Diagnostic:
Self-use by
people who
wish to
obtain
anonymous
HIV testing
Home Access
Health Corp.,
Hoffman
Estates, IL
7/22/1996 BP950002/0
Anti-HIV-1 Oral Specimen Collection Device
Trade
name(s)
(Labeling
may be
out of
date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
OraSure
HIV-1 Oral
Specimen
Collection
Device
HIV-1
Oral
Specimen
Collection
Device
Oral
Fluid
For Use with
HIV
diagnostic
assays that
have been
approved for
use with this
device.
OraSure
Technologies
Bethlehem,
PA
12/23/1994BP910001/0
Human Immunodeficiency Virus Type 2 (Anti-HIV-2 Assay)
Trade
name(s)
(Labeling
may be out
of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approval
Date
STN
GS HIV-2
EIA
HIV-2 EIA
Serum /
Plasma
Donor
Screen and
diagnostic.
Bio-Rad
Laboratories
Redmond,
WA US
License 1109
4/25/1990BL103227/0
Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agen
t
Format Current
Sample
Use
Manufactu
rer
Approva
l Date
STN
Abbott HIVAB
HIV-1/HIV-2
(rDNA) EIA
HIV-
1,
HIV-2
EIA
Serum /
Plasma /
Cadaveric
Serum
Donor Screen
and diagnostic
Abbott
Laboratorie
s Abbott
Park, IL US
License
0043
2/14/199
2
BL103385/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agen
t
Format Current
Sample
Use
Manufactu
rer
Approva
l Date
STN
ABBOTT PRISM
HIV O Plus
assay
HIV-
1,
HIV-2
Chemi-
luminesc
ent
Immunoa
ssay
(ChLIA)
Plasma /
Serum/
Cadaveric
Serum
Donor Screen:
Qualitative
detection of
antibodies to
HIV-1 (anti-
HIV-1) groups
M and O
and/or
antibodies to
HIV-2 (anti-
HIV-2) in
human serum
and plasma
specimens.
Organ donor
screening
when
specimens are
obtained while
the donor's
heart is still
beating, in
testing blood
specimens to
screen
cadaveric
(non-heart-
beating)
donors, and as
an aid in the
diagnosis of
HIV- 1 /HIV-2
infection
Abbott
Laboratorie
s Abbott
Park, IL US
License
0043
9/18/200
9
BL125318/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agen
t
Format Current
Sample
Use
Manufactu
rer
Approva
l Date
STN
GS HIV-1/HIV-2
Plus O EIA
HIV-
1,
HIV-2
EIA
Serum /
Plasma /
Cadaveric
Serum
Use with the
Ortho
Summit™
System (OSS)
in the
screening of
blood donors,
also for
diagnostics.
Diagnostic
detection of
antibodies to
HIV-1 (Groups
M and O)
and/or HIV-2 in
human serum,
plasma, and
cadaveric
serum
specimens.
Bio-Rad
Laboratorie
s
Redmond,
WA US
License
1109
8/5/2003
BL125030/0,
BL125030/10,
BL125030/24
ADVIA Centaur
HIV 1/O/2
Enhanced
ReadyPack
Reagents
HIV-
1,
HIV-2
Micropart
icle
Chemi-
luminom
etric
Immunoa
ssay
Plasma/
Serum
Diagnostic: For
qualitative
determination
of antibodies
to the human
immunodeficie
ncy virus type
1, including
Group O,
and/or type 2
in serum or
plasma
Siemens
Healthcare
Diagnostics
, Inc.
5/18/200
6
BP050030/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agen
t
Format Current
Sample
Use
Manufactu
rer
Approva
l Date
STN
Ortho VITROS
HIV-1/HIV-2
HIV-
1,
HIV-2
EIA
Plasma/
Serum
Diagnostic: For
use on the
VITROS®
5600
Integrated and
VITROS®
3600
Immunodiagno
stic Systems
Ortho-
Clinical
Diagnostics
, Inc
Raritan, NJ
US License
1236
3/27/200
8
BP050051/0,
BP050051/18
Multispot HIV-
1/HIV-2 Rapid
Test
HIV-
1,
HIV-2
Rapid
Immunoa
ssay
Plasma /
Serum
Diagnostic
Bio-Rad
Laboratorie
s
Redmond,
WA US
License
1109
11/12/20
04
BP040046/0
SURE CHECK
HIV 1/2 ASSAY
HIV-
1,
HIV-2
Rapid
Immunoa
ssay
Finger
stick &
venous
whole
blood,
serum,
plasma
Diagnostic
Chembio
Diagnostic
Systems,
Inc.
Medford,
NY
5/25/200
6
BP050009/0
HIV 1/2 STAT-
PAK ASSAY
HIV-
1,
HIV-2
Rapid
Immunoa
ssay
Finger
stick &
venous
whole
blood,
serum,
plasma
Diagnostic
Chembio
Diagnostic
Systems,
Inc.
Medford,
NY
5/25/200
6
BP050010/0
Trade name(s)
(Labeling may
be out of date)
Infec-
tious
Agen
t
Format Current
Sample
Use
Manufactu
rer
Approva
l Date
STN
OraQuick
ADVANCE Rapid
HIV-1/2 Antibody
Test
HIV-
1,
HIV-2
Rapid
Immunoa
ssay
Whole
Blood,
Plasma,
Oral Fluid
Diagnostic
OraSure
Technologi
es
Bethlehem,
PA
6/22/200
4
BP010047/16
OraQuick
ADVANCE Rapid
HIV-1/2 Antibody
Test
HIV-
1,
HIV-2
Rapid
Immunoa
ssay
oral fluid,
plasma,
venous
whole
blood
Diagnostic
OraSure
Technologi
es
Bethlehem,
PA
11/7/200
2
BP010047/0
Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay) and Anti-HIV-1
(HIV-1 Antigen Assay)
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufactur
er
Approval
Date
STN
ARCHITECT HIV
Ag/Ab Combo
HIV-1,
HIV-2
Chemi-
lumines
cent
Micropa
rticle
Immuno
assay
(CMIA)
Plasma /
Serum
Diagnostic:
For detection
of antibodies
to HIV-1 and
HIV-2 and
HIV-1 antigen
Abbott
Laboratorie
s Abbott
Park, IL US
License
0043
6/18/2010 BP090080
Bio-Rad GS HIV
Ag/Ab Combo EIA
HIV-1,
HIV-2
EIA
Plasma /
Serum
Diagnostic:
For detection
of antibodies
to HIV-1 and
HIV-2 and
HIV-1 antigen
as an aid in
the diagnosis
of HIV
infection,
including in
pediatric
populations
(children as
young as two
years old).
Bio-Rad
Laboratorie
s Redmond,
WA US
License
1109
7/22/2011 BP100064
Human T-Lymphotropic Virus Types I & II (Anti-HTLV-I/II Assay)
Trade name(s)
(Labeling may be
out of date)
Infec-
tious
Agent
Format Current
Sample
Use
Manufacturer Approv
al Date
STN
Abbott HTLV-I/HTLV-
II EIA
HTLV-1,
HTLV-2 EIA
Serum /
Plasma Donor Screen
Abbott
Laboratories
Abbott Park, IL
US License
0043
8/15/19
97
BL103614/0
ABBOTT PRISM
HTLV-I/HTLV-II
HTLV-1,
HTLV-2
Chemi-
lumines
cent
Immuno
assay
(ChLIA)
Serum /
Plasma
Donor Screen:
Screening test
for individual
human donors,
including
volunteer donors
of whole blood
and blood
components, and
other living
donors for the
presence of anti-
HTLV-I/HTLV-II.
Also intended for
use in testing
blood and
plasma to screen
organ donors
when specimens
are obtained
while the donor’s
heart is still
beating.
Abbott
Laboratories
Abbott Park, IL
US License
0043
1/16/20
08
BL103761/0
Regulation 4-2-10 FILING REQUIREMENTS FOR MULTIPLE EMPLOYER
WELFARE ARRANGEMENTS (MEWAS)
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
Filing Requirements of MEWAs Seeking Exemption Under § 10-3-
903.5(7)(c), C.R.S.
Section 6
Filing Requirements of MEWAs Seeking A Waiver Under § 10-3-
903.5(7)(d), C.R.S
Section 7
Authorized Insurance Arrangements
Section 8
Producer Responsibilities
Section 9
Continuing Compliance
Section 10
Severability
Section 11
Enforcement
Section 12
Effective Date
Section 13
History
Section 1
Authority
This regulation is promulgated and adopted by the Commissioner of Insurance under
the authority of §§ 10-1-109, C.R.S., and 10-3-903.5(7)(d)(V)(A), C.R.S.
Section 2
Scope and Purpose
This regulation is intended to clarify the information to be filed under the provisions of §
10-3-903.5(7)(c), C.R.S., by Multiple Employer Welfare Arrangements (MEWAs)
claiming exempt status from formal licensing requirements. Further, this regulation is
intended to clarify the application requirements under the provisions of § 10-3-
903.5(7)(d) by a MEWA seeking a waiver to operate in Colorado. This regulation also
clarifies the responsibilities of licensed producers with respect to MEWAs.
Section 3
Applicability
This regulation applies to multiple employer welfare arrangements subject to § 10-3–
903.5, C.R.S. For a MEWA seeking an exemption pursuant to § 10-3-903.5(7)(c),
C.R.S, the MEWA must comply with the requirements of Section 5. MEWAs seeking a
waiver pursuant to § 10-3-903.5(7)(d), C.R.S must comply with Section 6.
Section 4
Definitions
A.
“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S.
B.
“Covered lives” mean, for the purposes of this regulation, members, subscribers,
and dependents.
C.
“Fully insured” means, for the purposes of this regulation, an arrangement where
a licensed entity is liable to pay all health care benefits, less any contractual
deductibles, coinsurance or copayments to be made by the covered person. The
liability of the licensed entity for payment of the covered services or benefits is
directly to the individual employee, member or dependent(s) receiving the health
care services or benefits. The contract issuance, claims payment, administration,
and all other insurance related functions remain the ultimate responsibility of the
licensed entity.
D.
“Health plan” means, for the purposes of this regulation, an arrangement such as
a fund, trust, plan, program or other funding mechanism that provides health care
benefits.
E.
“Licensed entity” means, for the purposes of this regulation, a licensed insurance
company; health maintenance organization; or nonprofit hospital, medical-
surgical, and health service corporation having a certificate of authority to
transact business in this state.
F.
“Producer” means, for the purposes of this regulation, a licensed person as
defined by Article 2 of Title 10.
G.
“SERFF” means, for the purposes of this regulation, System for Electronic Rates
and Forms Filing.
H.
“Substantial compliance” means, for the purposes of this regulation, that each
benefit provided to an individual covered by a MEWA complies with the essential
requirements of each mandated benefit.
Section 5
Filing Requirements of MEWAs Seeking Exemption Under § 10-3-
903.5(7)(c), C.R.S.
A.
A filing under this Section 5 is solely for the purpose of providing information
required by the Commissioner to demonstrate a MEWA complies with the
requirements of § 10-3-903.5(7)(c), C.R.S. Determination of compliance or
noncompliance will be provided electronically via SERFF.
B.
The following information must be filed electronically in SERFF in order to meet
the filing requirements of § 10-3- 903.5(7)(c), C.R.S., and for the Commissioner
to make a determination regarding the qualification of a MEWA seeking
exemption from licensure requirements:
1.
Evidence that the MEWA has existed continuously since January 1, 1983.
2.
A copy of the sponsor association's organizational documents,
membership criteria, ownership information and a summary of the
activities and benefits, other than health plan coverage, provided to its
membership.
3.
A copy of the most recent financial report, which includes at a minimum, a
balance sheet, income statement, cash flow report and a detailed listing of
assets, as of the MEWA's most recent fiscal year end. The financial report
must support the required unallocated reserve level of not less than five
percent (5%) of the first two (2) million dollars for annual contributions
made to each arrangement in the preceding fiscal year.
4.
The method of marketing and enrolling eligible participants.
5.
The actuarial information required by § 10-3-903.5(7)(c)(III), C.R.S., that
must be prepared and signed by a qualified actuary. The actuarial
information must include:
a.
An opinion that:
(1)
Is prepared in a format consistent with that required by the
National Association of Insurance Commissioners for
commercial health insurers; and
(2)
Opines on the adequacy of the health plan reserves and
liabilities reflected in the financial report.
b.
A copy of the underlying actuarial report supporting such opinion, in
accordance with the requirements of § 10-7-114, C.R.S., including
all methods and assumptions employed. In addition, the report
must evaluate the adequacy of the contribution and funding levels
of the health plan for the current and immediately subsequent fiscal
year.
6.
A copy of the products offered along with a summary of benefits and a
comparison of how each benefit is in substantial compliance with
Colorado’s mandated benefit provisions.
7.
Such other relevant information as the Commissioner may request in
order to evaluate the qualification status of the MEWA.
8.
A copy of an audited annual financial report within 150 days of the
MEWA's fiscal year end.
C.
Subsections B.1. and B.2. are only required to be filed once, unless materially
altered. B.3. through B.7. must be filed annually within sixty (60) days following
the fiscal year end of the MEWA. Subsection B.8. must be filed annually.
Section 6
Filing Requirements of MEWAs Seeking A Waiver Under § 10-3-
903.5(7)(d), C.R.S.
A.
A MEWA seeking to submit a waiver application to operate in Colorado, as
provided in § 10-3-903.5(7)(d), C.R.S., must comply with this Section 6.
B.
Waiver application requirements.
1.
A MEWA must submit a waiver application to the Division including all
information and documentation outlined in § 10-3- 903.5(7)(d)(I), C.R.S.,
electronically via SERFF.
2.
As part of the application materials, a MEWA seeking a waiver must
demonstrate that it meets Colorado’s minimum solvency requirements as
outlined in Colorado Regulation 2-1-7.
C.
Annual filing requirements. A MEWA that is granted a waiver under § 10-3-
903.5(7)(d), C.R.S., must submit the following information to the Division on an
annual basis electronically via SERFF:
1.
Financial requirements.
a.
Annual financial statements as outlined in Colorado Regulations 3-
1-10 and 3-1-3.
b.
Risk-based capital requirements as outlined in Colorado
Regulations 2-1-7 and 3-1-12.
c.
Annual audited financial report as outlined in Colorado Regulation
3-1-4.
2.
Form filing requirements.
a.
All policy forms associated with the benefits and coverages offered
by the MEWA as outlined in Colorado Regulation 4-2-41.
b.
All marketing materials associated with the benefits and coverages
offered by the MEWA.
3.
Rate filing requirements.
a.
All rates associated with the benefits and coverages offered by the
MEWA as outlined in Colorado Regulation 4-2-39.
b.
For the purposes of rate review, the rates filed by a MEWA granted
a waiver under § 10-3-903.5(7)(d), C.R.S. will be evaluated based
on the number of covered lives with respect to the application of
small group or large group rate filing requirements.
4.
Network adequacy filing requirements.
a.
Information demonstrating compliance with Colorado network
adequacy standards as outlined in Colorado Regulations 4-2-53, 4-
2-54, 4-2-55, and 4-2-56.
Section 7
Authorized Insurance Arrangements
Insurance arrangements that are not subject to licensure as an insurer under Colorado
law are health plans that are:
A.
Fully insured;
B.
Established and maintained by a single employer;
C.
Established and subject to a collectively bargained agreement pursuant to § 10-
3-903.5(7)(b)(II), C.R.S.;
D.
Established by a government entity, pursuant to § 10-3-903.5(7)(b)(I), C.R.S.; or
E.
Determined to be in compliance with § 10-3-903.5(7)(c), C.R.S., and Section 5 of
this regulation.
Insurance arrangements granted a waiver pursuant to § 10-3-903.5(7)(d), C.R.S, and
this Section 6 remain subject to the Division’s full enforcement authority under Title 10,
and the Division may apply to the arrangement any requirements applicable to carriers
as long as the arrangement is operating in Colorado.
Section 8
Producer Responsibilities
No producer may solicit, advertise, market, accept an application, or place coverage for
a person who resides in this state with a MEWA unless the producer first verifies that
the MEWA complies with the requirements of this regulation and the provisions of § 10-
3-903.5(7), C.R.S. This is accomplished by the producer acquiring a copy of the
Division's correspondence determining that the MEWA is in compliance with this
regulation and the provisions of § 10-3-903.5(7)(c), C.R.S.
Lack of knowledge regarding the compliance of any organization or health plan is not a
defense to a violation of this regulation. Any producer involved in the solicitation or sale
of health plans through unauthorized insurers or MEWAs which are found not to be in
compliance with the provisions of § 10-3- 903.5(7), C.R.S. and this regulation are
subject to discipline or action including fines, suspension or revocation of his or her
license.
Section 9
Continuing Compliance
In the event that a MEWA ceases to qualify under Section 5 of this regulation, it will be
transacting the business of insurance in the State of Colorado without a license and
subject to the procedures of Parts 9 and 10 of Article 3 of Title 10, C.R.S., and the
provisions of the State Administrative Procedure Act, Part 4 of Title 24, C.R.S., as
applicable.
In the event a MEWA ceases to qualify for a waiver under Section 6, it will be
transacting the business of insurance in Colorado unlawfully and subject to the
procedures of Parts 9 and 10 of Article 3 of Title 10, C.R.S., and the provisions of the
State Administrative Procedure Act, Part 4 of Title 24, C.R.S., as applicable.
Section 10 Severability
If any provision of this regulation or the application of it to any person or circumstance is
for any reason held to be invalid, the remainder of this regulation shall not be affected.
Section 11 Enforcement
Noncompliance with this regulation may result in the imposition of any sanctions made
available in the Colorado statutes pertaining to the business of insurance, or other laws,
which include the imposition of civil penalties, issuance or cease and desist orders,
and/or suspensions or revocations of license, subject to the requirements of due
process.
Section 12 Effective Date
This amended regulation shall be effective May 30, 2022.
Section 13 History
Regulation 4-2-10, effective July 1, 1994
Amended regulation effective October 2, 2006
Amended regulation effective August 1, 2012
Amended regulation effective September 1, 2017
Amended regulation effective May 30, 2022
Regulation 4-2-11 RATE FILING SUBMISSIONS FOR LIMITED BENEFIT HEALTH
INSURANCE PLANS, EXCESS/STOP LOSS INSURANCE, LONG-TERM CARE
INSURANCE, MEDICARE SUPPLEMENT INSURANCE, SICKNESS AND ACCIDENT
INSURANCE, DISABILITY INCOME, DENTAL, OTHER THAN HEALTH BENEFIT
PLANS
Section 1
Authority
Section 2
Scope and Purpose
Section 3
Applicability
Section 4
Definitions
Section 5
General Rate Filing Requirements
Section 6
Actuarial Memorandum
Section 7
Additional Rate Filing Requirements for Long-term Care Insurance
Section 8
Additional Rate Filing Requirements for Medicare Supplement Policies
Section 9
Additional Rate Filing Requirements by Line of Business and by Market
Type
Section 10
Prohibited Rating Practices
Section 11
Wellness Benefit Requirements
Section 12
Severability
Section 13
Incorporation by Reference
Section 14
Enforcement
Section 15
Effective Date
Section 16
History
Appendix A: Determination of Credibility Weights in Case of Nationwide Experience Not
Reaching Full Credibility in the Most Recent 3 Years
Section 1
Authority
This regulation is promulgated and adopted by the Commissioner of Insurance under
the authority of §§ 10-1-109, 10-3-1110, 10-16-107, 10-16-109, 10-18-105(2), and 10-
19-113.7, C.R.S.
Section 2
Scope and Purpose
The purpose of this regulation is to ensure that health insurance rates on limited benefit
plans, excess/stop loss Insurance, sickness and accident insurance, disability income,
and other than health benefit plans, are not excessive, inadequate or unfairly
discriminatory, by establishing the requirements for rate filings.
Section 3
Applicability
This regulation applies to all carriers offering certain types of limited benefit insurance,
as found at § 10-16-102(32)(b), C.R.S., and including, but not limited to the following
types of coverage: dental, including dental coverage plans (except for plans covering
pediatric dental as an essential health benefit), long-term care, disability income
insurance, paid family and medical leave insurance, , Medicare supplement, prepaid
dental, supplemental health, travel accident/sickness, vision, and excess/stop loss
carriers for employers with self-insured health plans, and any other type of insurance
that does not meet the definition of a health benefit plan. This regulation does not apply
to short-term limited duration health insurance policies.
Section 4
Definitions
A.
“1990 Standardized Medicare supplement benefit plan” or “1990 plan” mean, for
the purposes of this regulation, a group or individual policy of Medicare
supplement insurance issued on or after May 1, 1992 and prior to June 1, 2010,
and includes Medicare supplement insurance policies and certificates renewed
on or after April 30, 1992 which are not replaced by the issuer at the request of
the insured.
B.
“2010 Standardized Medicare supplement benefit plan,” “2010 standardized
benefit plan,” or “2010 plan” mean, for the purposes of this regulation, a group or
individual policy of Medicare supplement insurance issued with an effective date
for coverage issued on or after June 1, 2010.
C.
“Accident-only policy” means, for the purposes of this regulation, coverage for
death, dismemberment, disability, and/or hospital and medical care caused by or
necessitated as the result of an accident or specified kinds of accident.
D.
“Accidental death and dismemberment coverage” means, for the purposes of this
regulation, an insurance policy that pays “stated benefits” in the event of death or
dismemberment caused by an accident. Medical care, disability income or other
coverages, such as hospitalization, outpatient surgery, other injury benefits, or
non-health coverages, shall be filed under the appropriate line of business for the
product.
E.
“Actuarial Memorandum” means, for the purposes of this regulation, the required
4-2-11 Rate Filing spreadsheet. The actuarial memorandum is the same as the
Regulation 4-2-11 Excel Template spreadsheet available in SERFF.
F
“Annual renewable term” means, for the purposes of this regulation, a policy that
provides insurance coverage for one year and allows the insured to continue
coverage under the policy without new evidence of insurability.
G.
“Benefits ratio” shall have the same meaning as found at § 10-16-102(5), C.R.S.
H.
“Blanket accident policy” means, for the purposes of this regulation,
supplemental limited benefit expense policy providing supplemental medical
benefits for accident-related medical losses. Benefits do not exceed a stated
dollar amount per day, per month. Requirements are included in Section 6.C. of
this regulation.
I.
“Blanket accident and sickness policy” means, for the purposes of this regulation,
supplemental health limited benefit expense policy providing medical benefits for
sickness-related or accident-related medical losses. Benefits are not to exceed a
stated dollar amount per day, per month. Requirements are included in Section
6.C. of this regulation.
J.
“Blanket sickness policy” means, for the purposes of this regulation, a
supplemental health limited benefit expense policy providing supplemental
medical benefits for sickness related medical losses. Requirements are included
in Section 6.C. of this regulation.
K.
“Carrier” shall have the same meaning as found at § 10-16-102(8), C.R.S. and
for the purposes of this regulation, shall also include issuers of Medicare
supplement policies.
L.
“Coordination of benefits” (COB) means, for the purposes of this regulation, a
provision establishing an order in which policies pay the claims and permitting
secondary policies to reduce the benefits so that the combined benefits of all
plans do not exceed the total allowable expenses. Requirements are included in
Section 6.C.
M.
“Covered lives” means, for the purposes of this regulation, the number of
members, subscribers and dependents.
N.
“Credibility” means, for the purposes of this regulation, the degree of accuracy in
predicting future events based on statistical reporting of past events. It is also a
measure of the predictive value an actuary attaches to a particular set of data.
1.
“Complement of credibility” means, for the purposes of this regulation,
related experience to supplement data that is not fully credible.
Complement of credibility is calculated as 1 – credibility.
2.
“Fully credible experience” means, for the purposes of this regulation, at
least 2000 life years and 2000 claims.
O.
“Dental coverage plan” shall have the same meaning as found at § 10-16-
165(1)(b), C.R.S.
P.
“Disability income policy” means, for the purposes of this regulation, a policy that
provides periodic payments to replace income lost when the insured is unable to
work as a result of a sickness or injury.
Q.
“Disabled Life Reserves” means, for the purposes of this regulation, the present
value of all future expected payments for known and open claims that were
incurred prior to the financial statement date (i.e., present value of amounts not
yet due).
R.
“Dividends” mean, for the purposes of this regulation, both policyholder and
stockholder dividends.
S.
“Effective date requested” means, for the purposes of this regulation, the specific
date that the filed or approved rates can be charged to an individual or group.
T.
“Excessive” means, for the purposes of this regulation, rates that are likely to
produce a long run profit that is unreasonably high for the insurance provided or
if the rates include a provision for expenses that is unreasonably high in relation
to the services rendered. In determining if the rate is excessive, the
Commissioner may consider profits, dividends, annual rate reports, annual
financial statements, subrogation funds credited, investment income or losses,
unearned premium reserve, reserve for losses, surpluses, executive salaries,
expected benefits ratios, and any other appropriate actuarial factor as
determined by accepted actuarial standards of practice. The Commissioner may
require the submission of additional relevant information deemed necessary in
determining whether to reject, approve or disapprove a rate filing.
U.
“File and Use” means, for the purposes of this regulation, a filing procedure that
does not require approval by the Commissioner prior to distribution, release to
producers, collection of premium, advertising, or any other use of the rate.
V.
“Filing date” means, for the purposes of this regulation, the date the rate filing is
received at the Division.
W.
“Health benefit plan” shall have the same meaning as found at § 10-16-102(32),
C.R.S.
X.
“Health care services” shall have the same meaning as found at § 10-16-102(33),
C.R.S.
Y.
“Health coverage plan” shall have the same meaning as found at § 10-16-
102(34), C.R.S. For purposes of this regulation, this definition shall not include
health benefit plans.
Z.
“Hospital indemnity coverage” means, for the purposes of this regulation,
supplemental coverage that provides a stated daily, weekly or monthly payment
while the insured is hospitalized, regardless of expenses incurred and regardless
of whether or not other insurance is in force.
AA.
“If-known” means, for the purposes of this regulation, the premium that would
have been charged from the time of issue if the carrier could have predicted that
the experience would develop as it has and the current assumptions were the
original pricing assumptions discounted using maximum statutory valuation rates.
AB.
“Inadequate” means, for the purposes of this regulation, rates that are insufficient
to sustain projected losses and expenses, or if the use of such rates, if
continued, will tend to create a monopoly in the marketplace. In determining if the
rate is inadequate, the Commissioner may consider profits, dividends, annual
rate reports, annual financial statements, subrogation funds credited, investment
income or losses, unearned premium reserve, reserve for losses, surpluses,
executive salaries, expected benefits ratios, and any other appropriate actuarial
factors as determined by accepted actuarial standards of practice. The
Commissioner may require the submission of additional relevant information
deemed necessary in determining whether to approve or disapprove a rate filing.
AC.
“Inadequate rates” means, for the purposes of this regulation, rates that are
clearly insufficient to sustain projected losses and expenses, or if the use of such
rates, if continued, will tend to create a monopoly in the marketplace. In
determining if the rate is inadequate, the Commissioner may consider profits,
dividends, annual rate reports, annual financial statements, subrogation funds
credited, investment income or losses, unearned premium reserve, reserve for
losses, surpluses, executive salaries, expected benefits ratios, and any other
appropriate actuarial factors as determined by accepted actuarial standards of
practice. The Commissioner may require the submission of whatever relevant
information the Commissioner deems necessary in determining whether to
approve or disapprove a rate filing.
AD.
“Incurred But Not Reported liabilities” or “IBNR liabilities” means, for the
purposes of this regulation, the present value of all future expected payments for
unknown open claims that were incurred prior to the financial statement date, but
not yet reported as of that date. Applies to both short and long term products.
AE.
“Indemnity policy” means, for the purposes of this regulation, coverage that
provides benefits based on an event incurred and pays a flat, fixed dollar amount
rather than expenses incurred on a medical expense basis.
AF.
“Insurance trend” means, for the purposes of this regulation, the combined effect
of any other items impacting medical trend, including the impact on trend due to
anticipated demographic changes. Insurance trend includes anti-selection
resulting from rate increases and discontinuance of new sales.
AG.
“Lifetime loss ratio” means, for the purposes of this regulation:
1.
The sum of the accumulated value of policy benefits from the inception of
the policy form(s) to the end of the experience period and the present
value of expected policy benefits over the entire future period for which the
proposed rates are expected to provide coverage; divided by:
2.
The sum of the accumulated value of earned premiums from the inception
of the policy form(s) to the end of the experience period and the present
value of expected earned premium over the entire future period for which
the proposed rates are expected to provide coverage.
Active life reserves do not represent claim payments, but provide for
timing differences. Therefore, active life reserves shall not be included in
this calculation. An appropriate interest rate should be used to calculate
the accumulated values and the present values of incurred losses and
earned premiums. If the statutory valuation rate is not used, the carrier
should explain why using a different discount rate is more appropriate.
AH.
“Lifetime loss ratio standard” means, for the purposes of this regulation, any
policy form or forms for which the benefits ratio in any policy duration is expected
to vary from the lifetime loss ratio.
AI.
“Limited benefit health coverage” means, for the purposes of this regulation, any
type of health coverage that is not provided by a health benefit plan, as found at
§ 10-16-102(32)(a), C.R.S.
AJ.
“Medical trend” means, for the purposes of this regulation, the combined effect of
medical provider price increases, utilization changes, medical cost shifting, new
medical procedures and technology, and other insurance trend. Medical trend
includes changes in unit costs of medical services or procedures, medical
provider price changes, changes in utilization (other than due to advancing age),
medical cost shifting, and new medical procedures and technology.
AK.
“New policy form or product” means, for the purposes of this regulation, a policy
form that has “substantially different new benefits” or unique characteristics
associated with risk or cost that are different from existing policy forms offered by
the company. For example, a guaranteed issue policy form is different from an
underwritten policy form, a managed care policy form is different from a non-
managed care policy form, and a direct written policy form is different from a
policy sold using producers, etc.
AL.
“Non-cancellable” means, for the purposes of this regulation, a policy which the
insured has the right to continue in force by the timely payment of premiums set
forth in the policy, during which period the insurer has no right to make
unilaterally any change in any provision of the policy while the policy is in force.
AM.
“On-rate level premium” means, for the purposes of this regulation, the premium
that would have been generated if the present rates had been in effect during the
entire period under consideration.
AN.
“Paid family and medical leave insurance” means, for the purposes of this
regulation, providing partial wage-replacement benefits to an eligible individual
who takes leave from work to care for a new child or a family member with a
serious health condition or who is unable to work due to the individual's own
serious health condition or when the individual or the individual’s family member
is a victim of domestic violence, stalking, or sexual assault or circumstances
related to a family member’s active duty military service.
AO.
“Plan” means, for the purposes of this regulation, the specific benefits and cost-
sharing provisions available to a covered person.
AP.
“Premium” shall have the same meaning as found at § 10-16-102(51), C.R.S.
AQ.
“Product(s)” means, for the purposes of this regulation, the services covered as a
package under a policy form by a carrier, which may have several cost-sharing
options and riders as options.
AR.
“Qualified actuary” means, for the purposes of this regulation, a member of the
American Academy of Actuaries or a person who has demonstrated to the
satisfaction of the Commissioner that the person has sufficient educational
background and who has no less than seven (7) years of recent actuarial
experience relevant to the area of qualifications, as defined in Colorado
Insurance Regulation 1-1-1.
AS.
“Rate” means, for purposes of this regulation, the amount of money a carrier
charges as a condition of providing health care coverage. The rate charged
normally reflects such factors as the carrier’s expectation of the insured’s future
claim costs, the insured’s share of the carrier’s claim settlement, operational and
administrative expenses, and the cost of capital. This amount is net of any
adjustments, discounts, allowances or other inducements permitted by the
contract.
AT.
“Rate filing(s)” means, for the purposes of this regulation, a filing(s) that contains
all of the items required in this regulation including the proposed base rates and
all rating factors, the underlying rating assumptions, support for new product
offerings and all changes in existing rates, factors and assumptions utilized,
including the continued use of trend factors.
AU.
“Rate increase” shall have the same meaning as found at § 10-16-102(57),
C.R.S., and, for the purposes of this regulation, includes increases in any current
rate or any factor, including trend factors, used to calculate premium rates for
new or existing policyholders, members or certificate holders.
AV.
“Rating period” shall have the same meaning as found at § 10-16-102(58),
C.R.S.
AW.
“Renewed” means, for the purposes of this regulation, a plan renewed upon the
occurrence of the earliest of the annual anniversary date of issue; the date on
which premium rates can be or are changed according to the terms of the plan;
or the date on which benefits can be or are changed according to the terms of
the plan. If the plan specifically allows for a change in premiums or benefits due
to changes in state or federal requirements and a change in the health coverage
plan premiums or benefits due solely to changes in state or federal requirements
are not considered a renewal in the health care coverage contract, then such a
change will not be considered a renewal for the purposes of this regulation.
AX.
“Retention” means, for the purposes of this regulation, the sum of all non-claim
expenses including investment income from unearned premium reserves,
contract or policy reserves, reserves from incurred losses, and reserves from
incurred but not reported losses as a percentage of total premium (or 100%
minus the lifetime loss ratio for products priced on a lifetime loss ratio standard).
AY.
“Review and Approval” means, for the purposes of this regulation, a filing
procedure that requires a rate change to be affirmatively approved by the
Commissioner prior to distribution, release to producers, collection of premium,
advertising, or any other use of the rate.
AZ.
“Sickness only policy” means, for the purposes of this regulation, limited benefit
expense coverage that only covers illness and disease and does not cover any
accidents.
BA.
“Specified disease policy” means, for the purposes of this regulation, payment of
benefits for the diagnosis and treatment of a specifically named disease or
diseases. Medical conditions resulting from accidents are not diseases and shall
not be included.
BB.
“SERFF” means, for the purposes of this regulation, System for Electronic Rate
and Form Filing.
BC.
“Travel insurance” means, for the purposes of this regulation, limited benefit
expense coverage providing medical benefits for losses incurred while traveling
generally outside a 100-mile radius of the US borders but may extend to
domestic as well as foreign travel. The policy may provide both sickness and
injury benefits, and air transportation services for medically necessary
emergencies.
BD.
“Trend” means, for the purposes of this regulation, any procedure for projecting
losses to the average date of loss, or of projecting premiums or exposures to the
average date of writing. Trend used solely for restating historical experience from
the experience period to the rating period, or which is used to project morbidity, is
considered a rating assumption.
BE.
“Trend factors” means, for purposes of this regulation, rates or rating factors that
vary over time or due to the duration that the insured has been covered under the
policy or certificate, and which reflect any of the components of medical or
insurance trend assumptions used in pricing.
BF.
“Unfairly discriminatory rates” means, for the purposes of this regulation,
charging different rates for the same benefits provided to individuals or groups,
with like expectations of loss; or if after allowing for practical limitations,
differences in rates which fail to equitably reflect the differences in expected
losses and expenses. A rate is not unfairly discriminatory solely if different
premiums result for policyholders with like loss exposures but different expenses,
or like expenses but different loss exposures, so long as the rate reflects the
differences with reasonable accuracy.
BG.
“Use of the rates” means, for the purposes of this regulation, the distribution of
rates or factors to calculate the premium amount for a specific policy or certificate
holder including advertising, distributing rates or premiums to producers, and
disclosing premium quotes. It does not include releasing information about the
proposed rating change to other government entities or disclosing general
information about the rate change to the public.
BH.
“Valid group” means, for the purposes of this regulation, a group that meets the
requirements as found in § 10-16-214(1), C.R.S.
BI.
“Wellness benefits” means, for the purposes of this regulation, health benefits
offered outside of the specifically defined line of coverage, such as annual
preventive care and health screening, including laboratory services, x-ray
services and similar services.
Section 5
General Rate and Dental Loss Ratio Filing Requirements
A.
Rate Filings except for Medicare supplement and Dental
1.
New Products
All New Product Filings are considered File & Use. Carriers must submit
rate filings to the Division prior to usage.
2.
Existing Products
a.
Any existing product without any Colorado policyholder receiving a
rate increase is considered File & Use.
b.
If any Colorado policyholder is projected to receive an increase, the
filing is considered Review & Approval.
B.
Medicare supplement Rate Filings
1.
All Medicare supplement filings are filed as Review & Approval.
2.
Medicare supplement carriers shall not use the r
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.